Supplier of key reagents for drug development.

+86-15801534258
info@nebulabio.cn
Drug Antibody References



Nebulabio Offers Series of Drug Antibody References

1734960218266839.jpg


  • Drug Antibody & It's Structure

Drug Antibody, also known as therapeutic antibodies, are biologically engineered proteins designed to specifically target and bind to antigens, such as proteins or cells, involved in diseases. Antibody drugs can be used to treat a wide range of conditions, including cancers, autoimmune diseases, infectious diseases, and inflammatory disorders. Molecular structures are including following types:

(1) Fully murine monoclonal antibodies and human-murine chimeric antibodies, such as Muromonab-CD3 (a fully murine monoclonal antibody) and Rituximab (a human-murine chimeric antibody);

(2) Antibodies with a higher degree of humanization, such as Trastuzumab and Nimotuzumab;

(3) Fully humanized antibodies, which are entirely encoded by human genes and significantly reduce immunogenicity, such as Adalimumab;

(4) Other forms of molecules, including antibody fusion proteins, antibody-drug conjugates, bispecific antibodies, small molecule antibody fragments and nanobodies.


  • Key Features of Antibody Drugs

Specificity: They bind to specific antigens with high precision, minimizing off-target effects.

Versatility: Antibody drugs can be engineered for various functions, such as blocking signaling pathways, recruiting immune cells, or delivering cytotoxic agents.

Diversity: They include monoclonal antibodies (mAbs), polyclonal antibodies, bispecific antibodies, antibody-drug conjugates (ADCs), and more.

Low Toxicity: Due to their specificity, they often have fewer side effects compared to traditional small-molecule drugs.


  • Antibody drug reference standards play a critical role in drug development, production, and quality control

(1) Candidate Screening in Drug Development: Used to evaluate the activity, specificity, and affinity of candidate antibodies; Help understand the mechanism of action and biological functions of antibodies; Serve as a reference in antibody engineering to optimize structure and function.

(2) Production Process: Serve as a reference to optimize production conditions; Used to monitor consistency and stability during the production process.

(3) Quality Control: Assess the potency and activity of the drug; Detect impurities and degradation products; Evaluate the stability of the drug under different conditions.

(4) Pharmacodynamic Studies: Help determine safe and effective dosages; Serve as a reference to assess potential efficacy.


Nebula Biotechnology Co., Ltd. possesses an abundant collection of standard samples for drug antibody research, all of which are expressed through CHO or HEK293 cells. These samples boast a purity level exceeding 99%, with endotoxin levels lower than 1 EU/mg, making them suitable for various in vivo and in vitro validation tests.


Drug Antibody NameTargetProduct NameCatalog Number
EnapotamabAXLHuman ALX Antibody (Enapotamab, Research Use)NBR-0001
TilvestamabAXLHuman ALX Antibody (Tilvestamab, Research Use)NBR-0002
AlsevalimabVTCN1Human B7-H4 Antibody (Alsevalimab, Research Use)NBR-0003
GSK2857916TNFRSF17Human BCMA Antibody (GSK2857916, Research Use)NBR-0004
LFB patent anti-BDCA-2BDCA-2Human BDCA-2 Antibody (LFB patent anti-BDCA-2, Research Use)NBR-0005
BIIB059BDCA-2Human BDCA-2 Antibody (BIIB059, Research Use)NBR-0006
InebilizumabCD19Human CD19 Antibody (Inebilizumab, Research Use)NBR-0007
TafasitamabCD19Human CD19 Antibody (Tafasitamab, Research Use)NBR-0008
RituximabCD20Human CD20 Antibody (Rituximab, Research Use)NBR-0009
ObinutuzumabCD20Human CD20 Antibody (Obinutuzumab, Research Use)NBR-0010
CixutumumabIGF-1RHuman IGF-1R Antibody (Cixutumumab, Research Use)NBR-0011
InotuzumabCD22Human CD22 Antibody (Inotuzumab, Research Use)NBR-0012
VarlilumabCD27Human CD27 Antibody (Varlilumab, Research Use)NBR-0013
BrentuximabCD30Human CD30 Antibody (Brentuximab, Research Use)NBR-0014
VadastuximabCD33Human CD33 Antibody (Vadastuximab, Research Use)NBR-0015
NaratuximabCD37Human CD37 Antibody (Naratuximab, Research Use)NBR-0016
DaratumumabCD38Human CD38 Antibody (Daratumumab, Research Use)NBR-0017
Magenta patent anti-CD5CD5Human CD5 Antibody (Magenta patent anti-CD5, Research Use)NBR-0018
Persongen patent anti-CD7CD7Human CD7 Antibody (Persongen patent anti-CD7, Research Use)NBR-0019
VorsetuzumabCD27L / CD70Human CD27L / CD70 Antibody (Vorsetuzumab, Research Use)NBR-0020
Amivantamabc-Met / HGFRHuman c-Met / HGFR Antibody (Amivantamab, Research Use)NBR-0021
Telisotuzumabc-Met / HGFRHuman c-Met / HGFR Antibody (Telisotuzumab, Research Use)NBR-0022
Onartuzumabc-Met / HGFRHuman c-Met / HGFR Antibody (Onartuzumab, Research Use)NBR-0023
PamrevlumabCTGFHuman CTGF Antibody (Pamrevlumab, Research Use)NBR-0024
IpilimumabCTLA-4Human CTLA-4 Antibody (Ipilimumab, Research Use)NBR-0025
QuetmolimabCX3CL1Human CX3CL1 Antibody (Quetmolimab, Research Use)NBR-0026
UlocuplumabCXCR4Human CXCR4 Antibody (Ulocuplumab, Research Use)NBR-0027
MEN1309DEC-205Human DEC-205 Antibody (MEN1309, Research Use)NBR-0028
CDX-1401DEC-205Human DEC-205 Antibody (CDX-1401, Research Use)NBR-0029
RovalpituzumabDLL3Human DLL3 Antibody (Rovalpituzumab, Research Use)NBR-0030
Dragonfly patent anti-DLL3DLL3Human DLL3 Antibody (Dragonfly patent anti-DLL3, Research Use)NBR-0031
ConatumumabDR5Human DR5 / TRAILR2 Antibody (Conatumumab, Research Use)NBR-0032
TigatuzumabDR5 / TRAILR2Human DR5 / TRAILR2 Antibody (Tigatuzumab, Research Use)NBR-0033
CetuximabEGFRHuman EGFR Antibody (Cetuximab, Research Use)NBR-0034
MEDI-547EphA2Human EphA2 Antibody (MEDI-547, Research Use)NBR-0035
Sanofi Aventis patent anti-EphA2EphA2Human EphA2 Antibody (Sanofi Aventis patent anti-EphA2, Research Use)NBR-0036
RozanolixizumabFcRnHuman FcRn Antibody (Rozanolixizumab, Research Use)NBR-0037
BemarituzumabFGFR2Human FGFR2 Antibody (Bemarituzumab, Research Use)NBR-0038
AprutumabFGFR2Human FGFR2 Antibody (Aprutumab, Research Use)NBR-0039
FarletuzumabFRAHuman FRA Antibody (Farletuzumab, Research Use)NBR-0040
MirvetuximabFRAHuman FRA Antibody (Mirvetuximab, Research Use)NBR-0041
CodrituzumabGPC3Human GPC3 Antibody (Codrituzumab, Research Use)NBR-0042
DisitamabHER2Human HER2 Antibody (Disitamab, Research Use)NBR-0043
ZanidatamabHER2Human HER2 Antibody (Zanidatamab, Research Use)NBR-0044
TrastuzumabHER2Human HER2 Antibody (Trastuzumab, Research Use)NBR-0045
PertuzumabHER2Human HER2 Antibody (Pertuzumab, Research Use)NBR-0046
OrdesekimabIL-15Human IL-15 Antibody (Ordesekimab, Research Use)NBR-0047
BrodalumabIL-17RAHuman IL-17RA Antibody (Brodalumab, Research Use)NBR-0048
GSK 1070806IL-18Human IL-18 Antibody (GSK 1070806, Research Use)NBR-0049
NidanilimabIL-1RAPHuman IL-1RAP Antibody (Nidanilimab, Research Use)NBR-0050
Lilly patent anti-IL-21IL-21Human IL-21 Antibody (Lilly patent anti-IL-21, Research Use)NBR-0051
ClazakizumabIL-6Human IL-6 Antibody (Clazakizumab, Research Use)NBR-0052
VobarilizumabIL-6RHuman IL-6R Antibody (Vobarilizumab, Research Use)NBR-0053
SarilumabIL-6RHuman IL-6R Antibody (Sarilumab, Research Use)NBR-0054
TocilizumabIL-6RHuman IL-6R Antibody (Tocilizumab, Research Use)NBR-0055
LirilumabKIRHuman KIR Antibody (Lirilumab, Research Use)NBR-0056
LacutamabKIR3DL2Human KIR3DL2 Antibody (Lacutamab, Research Use)NBR-0057
MSC-1LIFHuman LIF Antibody (MSC-1, Research Use)NBR-0058
Merck patent anti-ILT3 complexLILRB4Human LILRB4 Antibody (Merck patent anti-ILT3 complex, Research Use)NBR-0059
U.Texas patent anti-LILRB4LILRB4Human LILRB4 Antibody (U.Texas patent anti-LILRB4, Research Use)NBR-0060
LacnotuzumabM-CSFHuman M-CSF Antibody (Lacnotuzumab, Research Use)NBR-0061
EnfortumabNectin-4Human Nectin-4 Antibody (Enfortumab, Research Use)NBR-0062
TesnatilimabNKG2DHuman NKG2D Antibody (Tesnatilimab, Research Use)NBR-0063
OleclumabNT5EHuman NT5E Antibody (Oleclumab, Research Use)NBR-0064
SpartalizumabPD-1Human PD-1 Antibody (Spartalizumab, Research Use)NBR-0065
CamrelizumabPD-1Human PD-1 Antibody (Camrelizumab, Research Use)NBR-0066
PembrolizumabPD-1Human PD-1 Antibody (Pembrolizumab, Research Use)NBR-0067
NivolumabPD-1Human PD-1 Antibody (Nivolumab, Research Use)NBR-0068
MOR-8457PDGFBHuman PDGFB Antibody (MOR-8457, Research Use)NBR-0069
AvelumabPD-L1Human PD-L1 Antibody (Avelumab, Research Use)NBR-0070
MDX-1105PD-L1Human PD-L1 Antibody (MDX-1105, Research Use)NBR-0071
AtezolizumabPD-L1Human PD-L1 Antibody (Atezolizumab, Research Use)NBR-0072
DurvalumabPD-L1Human PD-L1 Antibody (Durvalumab, Research Use)NBR-0073
Genentech anti-PMEL17PMEL17Human PMEL17 Antibody (Genentech anti-PMEL17, Research Use)NBR-0074
Novartis patent anti-PMEL17PMEL17Human PMEL17 Antibody (Novartis patent anti-PMEL17, Research Use)NBR-0075
InclacumabP-SelectinHuman P-Selectin Antibody (Inclacumab, Research Use)NBR-0076
CrizanlizumabP-SelectinHuman P-Selectin Antibody (Crizanlizumab, Research Use)NBR-0077
NeihulizumabPSGL1Human PSGL1 Antibody (Neihulizumab, Research Use)NBR-0078
RosopatamabPSMAHuman PSMA Antibody (Rosopatamab, Research Use)NBR-0079
ElezanumabRGMAHuman RGMA Antibody (Elezanumab, Research Use)NBR-0080
ZilovertamabROR1Human ROR1 Antibody (Zilovertamab, Research Use)NBR-0081
NC318Siglec-15Human Siglec-15 Antibody (NC318, Research Use)NBR-0082
LirentelimabSiglec-8Human Siglec-8 Antibody (Lirentelimab, Research Use)NBR-0083
ElotuzumabSLAMF7Human SLAMF7 Antibody (Elotuzumab, Research Use)NBR-0084
TiragolumabTIGITHuman TIGIT Antibody (Tiragolumab, Research Use)NBR-0085
AdalimumabTNFaHuman TNFa Antibody (Adalimumab, Research Use)NBR-0086
InfliximabTNFaHuman TNFa Antibody (Infliximab, Research Use)NBR-0087
BevacizumabVEGFAHuman VEGFA Antibody (Bevacizumab, Research Use)NBR-0088
RamucirumabKDR / VEGFR2Human KDR / VEGFR2 Antibody (Ramucirumab, Research Use)NBR-0089
Utomilumab4-1BBHuman 4-1BB Antibody (Utomilumab, Research Use)NBR-0090
Urelumab4-1BBHuman 4-1BB Antibody (Urelumab, Research Use)NBR-0091
Abbvie patent anti-TNFSF94-1BBLHuman 4-1BBL Antibody (Abbvie patent anti-TNFSF9, Research Use)NBR-0092
DS-6016aACVR1Human ACVR1 Antibody (DS-6016a, Research Use)NBR-0093
Ab-14E1ACVR2AHuman ACVR2A Antibody (Ab-14E1, Research Use)NBR-0094
BimagrumabACVR2BHuman ACVR2B Antibody (Bimagrumab, Research Use)NBR-0095
PraluzatamabALCAMHuman ALCAM Antibody (Praluzatamab, Research Use)NBR-0096
AT002ALCAMHuman ALCAM Antibody (AT002, Research Use)NBR-0097
AscrinvacumabALK-1Human ALK-1 Antibody (Ascrinvacumab, Research Use)NBR-0098
CinpanemabAlpha-synucleinHuman Alpha-synuclein Antibody (Cinpanemab, Research Use)NBR-0099
PrasinezumabAlpha-synucleinHuman Alpha-synuclein Antibody (Prasinezumab, Research Use)NBR-0100
NesvacumabAngiopoietin-2Human Angiopoietin-2 Antibody (Nesvacumab, Research Use)NBR-0101
EvinacumabAngiopoietin-like3Human Angiopoietin-like3 Antibody (Evinacumab, Research Use)NBR-0102
DezamizumabAPCSHuman APCS Antibody (Dezamizumab, Research Use)NBR-0103
BION-1301APRILHuman APRIL Antibody (BION-1301, Research Use)NBR-0104
EnoblituzumabB7-H3Human B7-H3 Antibody (Enoblituzumab, Research Use)NBR-0105
OnvatilimabB7-H5 / VISTAHuman B7-H5 / VISTA Antibody (Onvatilimab, Research Use)NBR-0106
Dartmouth patent anti-B7-H6B7-H6Human B7-H6 Antibody (Dartmouth patent anti-B7-H6, Research Use)NBR-0107
BelimumabBAFFHuman BAFF Antibody (Belimumab, Research Use)NBR-0108
U.Toronto patent anti-BaxBcl-2Human Bcl-2 Antibody (U.Toronto patent anti-Bax, Research Use)NBR-0109
RG7992Beta-KlothoHuman Beta-Klotho Antibody (RG7992, Research Use)NBR-0110
NGM313Beta-KlothoHuman Beta-Klotho Antibody (NGM313, Research Use)NBR-0111
XmAb 5592BST2Human BST2 Antibody (XmAb 5592, Research Use)NBR-0112
SutimlimabC1sHuman C1s Antibody (Sutimlimab, Research Use)NBR-0113
G2_anti-C5aRC5aRHuman C5aR Antibody (G2_anti-C5aR, Research Use)NBR-0114
HKT288+D116Cadherin-6Human Cadherin-6 Antibody (HKT288+D116, Research Use)NBR-0115
GirentuximabCAIXHuman CAIX Antibody (Girentuximab, Research Use)NBR-0116
Fsn0503hCathepsin SHuman Cathepsin S Antibody (Fsn0503h, Research Use)NBR-0117
VLST-002CCL5Human CCL5 Antibody (VLST-002, Research Use)NBR-0118
PlozalizumabCCR2Human CCR2 Antibody (Plozalizumab, Research Use)NBR-0119
MogamulizumabCCR4Human CCR4 Antibody (Mogamulizumab, Research Use)NBR-0120
R707CCR7Human CCR7 Antibody (R707, Research Use)NBR-0121
LOP628CD117Human CD117 Antibody (LOP628, Research Use)NBR-0122
SNG-CD123AIL-3RAHuman IL-3RA Antibody (SNG-CD123A, Research Use)NBR-0123
TalacotuzumabIL-3RAHuman IL-3RA Antibody (Talacotuzumab, Research Use)NBR-0124
Forerunner patent anti-Prominin-1CD133Human CD133 Antibody (Forerunner patent anti-Prominin-1, Research Use)NBR-0125
SamalizumabCD200Human CD200 Antibody (Samalizumab, Research Use)NBR-0126
Janssen patent anti-CD200R1CD200RHuman CD200R Antibody (Janssen patent anti-CD200R1, Research Use)NBR-0127
BasiliximabCD25 / IL-1RAHuman CD25 / IL-1RA Antibody (Basiliximab, Research Use)NBR-0128
BelantamabBCMAHuman BCMA Antibody (Belantamab, Research Use)NBR-0129
VIB9600CD32aHuman CD32a Antibody (VIB9600, Research Use)NBR-0130
TTX-030CD39Human CD39 Antibody (TTX-030, Research Use)NBR-0131
BleselumabCD40Human CD40 Antibody (Bleselumab, Research Use)NBR-0132
SotigalimabCD40Human CD40 Antibody (Sotigalimab, Research Use)NBR-0133
DacetuzumabCD40Human CD40 Antibody (Dacetuzumab, Research Use)NBR-0134
FOR46CD46Human CD46 Antibody (FOR46, Research Use)NBR-0135
MagrolimabCD47Human CD47 Antibody (Magrolimab, Research Use)NBR-0136
CC-90002CD47Human CD47 Antibody (CC-90002, Research Use)NBR-0137
AlemtuzumabCD52Human CD52 Antibody (Alemtuzumab, Research Use)NBR-0138
LorvotuzumabCD56Human CD56 Antibody (Lorvotuzumab, Research Use)NBR-0139
Genefrontier patent anti-CD69CD69Human CD69 Antibody (Genefrontier patent anti-CD69, Research Use)NBR-0140
PolatuzumabCD79b / Ig BHuman CD79b / Ig B Antibody (Polatuzumab, Research Use)NBR-0141
U.California patent anti-CDCP1CDCP1Human CDCP1 Antibody (U.California patent anti-CDCP1, Research Use)NBR-0142
LabetuzumabCEAHuman CEA Antibody (Labetuzumab, Research Use)NBR-0143
CM-24CEACAM1Human CEACAM1 Antibody (CM-24, Research Use)NBR-0144
NEO-201CEACAM6Human CEACAM6 Antibody (NEO-201, Research Use)NBR-0145
Brown U. patent anti-CHI3L1Chitinase3-like1Human Chitinase3-like1 Antibody (Brown U. patent anti-CHI3L1, Research Use)NBR-0146
GSK3050002CK-B4Human CK-B4 Antibody (GSK3050002, Research Use)NBR-0147
FA19-1CLCP1Human CLCP1 Antibody (FA19-1, Research Use)NBR-0148
ZolbetuximabCLDN18Human CLDN18 Antibody (Zolbetuximab, Research Use)NBR-0149
IMAB027CLDN6Human CLDN6 Antibody (IMAB027, Research Use)NBR-0150
TepoditamabCLEC12AHuman CLEC12A Antibody (Tepoditamab, Research Use)NBR-0151
Scripps Korea patent anti-CLEC14ACLEC14AHuman CLEC14A Antibody (Scripps Korea patent anti-CLEC14A, Research Use)NBR-0152
Oxford Bio patent anti-CRTAMCRTAMHuman CRTAM Antibody (Oxford Bio patent anti-CRTAM, Research Use)NBR-0153
CabiralizumabCSF1RHuman CSF1R Antibody (Cabiralizumab, Research Use)NBR-0154
Med. Bio. Labs patent anti-CXADRCXADRHuman CXADR Antibody (Med. Bio. Labs patent anti-CXADR, Research Use)NBR-0155
EldelumabCXCL10Human CXCL10 Antibody (Eldelumab, Research Use)NBR-0156
Novimmune patent anti-CXCL9CXCL9Human CXCL9 Antibody (Novimmune patent anti-CXCL9, Research Use)NBR-0157
SAR113244CXCR5Human CXCR5 Antibody (SAR113244, Research Use)NBR-0158
INSERM patent anti-DC-SIGNDC-SIGNHuman DC-SIGN Antibody (INSERM patent anti-DC-SIGN, Research Use)NBR-0159
Baylor patent anti-Dectin-1Dectin-1Human Dectin-1 Antibody (Baylor patent anti-Dectin-1, Research Use)NBR-0160
BHQ-880DKK1Human DKK1 Antibody (BHQ-880, Research Use)NBR-0161
DemcizumabDLL4Human DLL4 Antibody (Demcizumab, Research Use)NBR-0162
NavicixizumabDLL4Human DLL4 Antibody (Navicixizumab, Research Use)NBR-0163
Abbvie patent anti-TNFRSF21DR6Human DR6 Antibody (Abbvie patent anti-TNFRSF21, Research Use)NBR-0164
CitatuzumabEPCAMHuman EPCAM Antibody (Citatuzumab, Research Use)NBR-0165
Genentech patent anti-EphB2EphB2Human EphB2 Antibody (Genentech patent anti-EphB2, Research Use)NBR-0166
Morphosys patent anti-EphB4EphB4Human EphB4 Antibody (Morphosys patent anti-EphB4, Research Use)NBR-0167
VasGene patent anti-EphB4EphB4Human EphB4 Antibody (VasGene patent anti-EphB4, Research Use)NBR-0168
Roche patent anti-Her3 / Her4ErbB4Human ErbB4 Antibody (Roche patent anti-Her3 / Her4, Research Use)NBR-0169
Abbott patent anti-EPO ReceptorErythropoietinRHuman ErythropoietinR Antibody (Abbott patent anti-EPO Receptor, Research Use)NBR-0170
SibrotuzumabFAPHuman FAP Antibody (Sibrotuzumab, Research Use)NBR-0171
LY2928057FerroportinHuman Ferroportin Antibody (LY2928057, Research Use)NBR-0172
Amgen patent anti-FerroportinFerroportinHuman Ferroportin Antibody (Amgen patent anti-Ferroportin, Research Use)NBR-0173
1A6FGF19Human FGF19 Antibody (1A6, Research Use)NBR-0174
HuGAL-F2FGF2Human FGF2 Antibody (HuGAL-F2, Research Use)NBR-0175
LY3076226FGFR3Human FGFR3 Antibody (LY3076226, Research Use)NBR-0176
VofatamabFGFR3Human FGFR3 Antibody (Vofatamab, Research Use)NBR-0177
U3-1784FGFR4Human FGFR4 Antibody (U3-1784, Research Use)NBR-0178
L19-TNFFibronectinHuman Fibronectin Antibody (L19-TNF, Research Use)NBR-0179
IMC-EB10FLT3Human FLT3 Antibody (IMC-EB10, Research Use)NBR-0180
U.Toronto patent anti-FZD7Frizzled-7Human Frizzled-7 Antibody (U.Toronto patent anti-FZD7, Research Use)NBR-0181
CrotedumabGCGRHuman GCGR Antibody (Crotedumab, Research Use)NBR-0182
VolagidemabGCGRHuman GCGR Antibody (Volagidemab, Research Use)NBR-0183
CSL patent anti-G-CSFRG-CSFRHuman G-CSFR Antibody (CSL patent anti-G-CSFR, Research Use)NBR-0184
Amgen patent anti-GIPRGIPRHuman GIPR Antibody (Amgen patent anti-GIPR, Research Use)NBR-0185
RagifilimabGITRHuman GITR Antibody (Ragifilimab, Research Use)NBR-0186
MavrilimumabGM-CSF2RAHuman GM-CSF2RA Antibody (Mavrilimumab, Research Use)NBR-0187
Regeneron patent anti-GP130 / LEPRGp130Human Gp130 Antibody (Regeneron patent anti-GP130 / LEPR, Research Use)NBR-0188
KRN330GPA33Human GPA33 Antibody (KRN330, Research Use)NBR-0189
GlembatumumabGPNMBHuman GPNMB Antibody (Glembatumumab, Research Use)NBR-0190
BNC101GPR49Human GPR49 Antibody (BNC101, Research Use)NBR-0191
PetosemtamabGPR49Human GPR49 Antibody (Petosemtamab, Research Use)NBR-0192
TalquetamabGPRC5DHuman GPRC5D Antibody (Talquetamab, Research Use)NBR-0193
UCB patent anti-Gremlin-1GremlinHuman Gremlin Antibody (UCB patent anti-Gremlin-1, Research Use)NBR-0194
KHK patent anti-HaptoglobinHaptoglobinHuman Haptoglobin Antibody (KHK patent anti-Haptoglobin, Research Use)NBR-0195
KHK2866HB-EGFHuman HB-EGF Antibody (KHK2866, Research Use)NBR-0196
U3-1565HB-EGFHuman HB-EGF Antibody (U3-1565, Research Use)NBR-0197
PatritumabHER3Human HER3 Antibody (Patritumab, Research Use)NBR-0198
SeribantumabHER3Human HER3 Antibody (Seribantumab, Research Use)NBR-0199
FiclatuzumabHGF / SFHuman HGF / SF Antibody (Ficlatuzumab, Research Use)NBR-0200
RilotumumabHGF / SFHuman HGF / SF Antibody (Rilotumumab, Research Use)NBR-0201
Emibetuzumabc-Met / HGFRHuman c-Met / HGFR Antibody (Emibetuzumab, Research Use)NBR-0202
VopratelimabICOSHuman ICOS Antibody (Vopratelimab, Research Use)NBR-0203
FeladilimabICOSHuman ICOS Antibody (Feladilimab, Research Use)NBR-0204
LIMR patent anti-IDO2IDO2Human IDO2 Antibody (LIMR patent anti-IDO2, Research Use)NBR-0205
RontalizumabIFNA1Human IFNA1 Antibody (Rontalizumab, Research Use)NBR-0206
SifalimumabIFNA1Human IFNA1 Antibody (Sifalimumab, Research Use)NBR-0207
XentuzumabIGF-1Human IGF-1 Antibody (Xentuzumab, Research Use)NBR-0208
TeprotumumabIGF-1RHuman IGF-1R Antibody (Teprotumumab, Research Use)NBR-0209
UstekinumabIL-12Human IL-12 Antibody (Ustekinumab, Research Use)NBR-0210
AnrukinzumabIL-13Human IL-13 Antibody (Anrukinzumab, Research Use)NBR-0211
Wake Forest U. patent anti-IL-13RA2IL-13RA2Human IL-13RA2 Antibody (Wake Forest U. patent anti-IL-13RA2, Research Use)NBR-0212
MOR106IL-17CHuman IL-17C Antibody (MOR106, Research Use)NBR-0213
AMG 108IL-1R1Human IL-1R1 Antibody (AMG 108, Research Use)NBR-0214
SpesolimabIL-1RL2Human IL-1RL2 Antibody (Spesolimab, Research Use)NBR-0215
ImsidolimabIL-1RL2Human IL-1RL2 Antibody (Imsidolimab, Research Use)NBR-0216
FletikumabIL-20Human IL-20 Antibody (Fletikumab, Research Use)NBR-0217
Cheng Kung U. patent anti-IL-20R1IL-20RAHuman IL-20RA Antibody (Cheng Kung U. patent anti-IL-20R1, Research Use)NBR-0218
FezakinumabIL-22Human IL-22 Antibody (Fezakinumab, Research Use)NBR-0219
GuselkumabIL-23Human IL-23 Antibody (Guselkumab, Research Use)NBR-0220
TildrakizumabIL-23P19Human IL-23P19 Antibody (Tildrakizumab, Research Use)NBR-0221
Singapore ASTR patent anti-IL-2R beta / IL-2R gamma IL-2RBHuman IL-2RB Antibody (Singapore ASTR patent anti-IL-2R beta / IL-2R gamma , Research Use)NBR-0222
DaclizumabIL-2RAHuman IL-2RA Antibody (Daclizumab, Research Use)NBR-0223
NemolizumabIL-31RAHuman IL-31RA Antibody (Nemolizumab, Research Use)NBR-0224
EtokimabIL-33Human IL-33 Antibody (Etokimab, Research Use)NBR-0225
PascolizumabIL-4Human IL-4 Antibody (Pascolizumab, Research Use)NBR-0226
DupilumabIL-4RAHuman IL-4RA Antibody (Dupilumab, Research Use)NBR-0227
MepolizumabIL-5Human IL-5 Antibody (Mepolizumab, Research Use)NBR-0228
BenralizumabIL-5RAHuman IL-5RA Antibody (Benralizumab, Research Use)NBR-0229
LusvertikimabIL-7RAHuman IL-7RA Antibody (Lusvertikimab, Research Use)NBR-0230
HuMax-IL8IL-8Human IL-8 Antibody (HuMax-IL8, Research Use)NBR-0231
Enokizumab IL-9Human IL-9 Antibody (Enokizumab , Research Use)NBR-0232
Innate patent anti-KIR2DL  KIR2DL1Human KIR2DL1 Antibody (Innate patent anti-KIR2DL  , Research Use)NBR-0233
RelatlimabLAG3Human LAG3 Antibody (Relatlimab, Research Use)NBR-0234
Brigham and Womens anti-LAPLAPHuman LAP Antibody (Brigham and Womens anti-LAP, Research Use)NBR-0235
MibavademabLEPRHuman LEPR Antibody (Mibavademab, Research Use)NBR-0236
MB 311LeYHuman LeY Antibody (MB 311, Research Use)NBR-0237
JTX-8064LILRB2Human LILRB2 Antibody (JTX-8064, Research Use)NBR-0238
SimtuzumabLOXL2Human LOXL2 Antibody (Simtuzumab, Research Use)NBR-0239
OntamalimabMAdCAM-1Human MAdCAM-1 Antibody (Ontamalimab, Research Use)NBR-0240
RefanezumabMAGHuman MAG Antibody (Refanezumab, Research Use)NBR-0241
CT Atlantic patent anti-MAGE-A3MAGE-A3Human MAGE-A3 Antibody (CT Atlantic patent anti-MAGE-A3, Research Use)NBR-0242
NarsoplimabMASP-2Human MASP-2 Antibody (Narsoplimab, Research Use)NBR-0243
RGX-019MERTKHuman MERTK Antibody (RGX-019, Research Use)NBR-0244
AmatuximabMesothelinHuman Mesothelin Antibody (Amatuximab, Research Use)NBR-0245
AnetumabMesothelinHuman Mesothelin Antibody (Anetumab, Research Use)NBR-0246
ImalumabMIFHuman MIF Antibody (Imalumab, Research Use)NBR-0247
AndecaliximabMMP-9Human MMP-9 Antibody (Andecaliximab, Research Use)NBR-0248
EnsituximabMU5ACHuman MU5AC Antibody (Ensituximab, Research Use)NBR-0249
ClivatuzumabMUC1Human MUC1 Antibody (Clivatuzumab, Research Use)NBR-0250
OregovomabMUC16Human MUC16 Antibody (Oregovomab, Research Use)NBR-0251
SofituzumabCA125Human CA125 Antibody (Sofituzumab, Research Use)NBR-0252
LandogrozumabMyostatinHuman Myostatin Antibody (Landogrozumab, Research Use)NBR-0253
TrevogrumabMyostatinHuman Myostatin Antibody (Trevogrumab, Research Use)NBR-0254
FulranumabNGFHuman NGF Antibody (Fulranumab, Research Use)NBR-0255
TanezumabNGFHuman NGF Antibody (Tanezumab, Research Use)NBR-0256
MonalizumabNKG2AHuman NKG2A Antibody (Monalizumab, Research Use)NBR-0257
OzanezumabNogo-AHuman Nogo-A Antibody (Ozanezumab, Research Use)NBR-0258
BrontictuzumabNotch1Human Notch1 Antibody (Brontictuzumab, Research Use)NBR-0259
VesencumabNRP1Human NRP1 Antibody (Vesencumab, Research Use)NBR-0260
TavolixizumabOX40Human OX40 Antibody (Tavolixizumab, Research Use)NBR-0261
OxelumabOX40LHuman OX40L Antibody (Oxelumab, Research Use)NBR-0262
AlirocumabPCSK9Human PCSK9 Antibody (Alirocumab, Research Use)NBR-0263
Thrombogenics patent anti-PDGF-CPDGFCHuman PDGFC Antibody (Thrombogenics patent anti-PDGF-C, Research Use)NBR-0264
TovetumabPDGFRAHuman PDGFRA Antibody (Tovetumab, Research Use)NBR-0265
OlaratumabPDGFRAHuman PDGFRA Antibody (Olaratumab, Research Use)NBR-0266
RinucumabPDGFRBHuman PDGFRB Antibody (Rinucumab, Research Use)NBR-0267
Novo Nordisk patent anti-PGLYRP1PGLYRP1Human PGLYRP1 Antibody (Novo Nordisk patent anti-PGLYRP1, Research Use)NBR-0268
Diaccurate patent anti-sPLA2-GIBPLA2G1BHuman PLA2G1B Antibody (Diaccurate patent anti-sPLA2-GIB, Research Use)NBR-0269
Eureka patent anti-PRAMEPRAMEHuman PRAME Antibody (Eureka patent anti-PRAME, Research Use)NBR-0270
AGS-1C4D4PSCAHuman PSCA Antibody (AGS-1C4D4, Research Use)NBR-0271
GSK4381562PVRIGHuman PVRIG Antibody (GSK4381562, Research Use)NBR-0272
COM701PVRIGHuman PVRIG Antibody (COM701, Research Use)NBR-0273
XT-M4RAGEHuman RAGE Antibody (XT-M4, Research Use)NBR-0274
DenosumabRANKLHuman RANKL Antibody (Denosumab, Research Use)NBR-0275
NarnatumabRONHuman RON Antibody (Narnatumab, Research Use)NBR-0276
Oncomed patent anti-RSPO1RSPO1Human RSPO1 Antibody (Oncomed patent anti-RSPO1, Research Use)NBR-0277
RosmantuzumabRSPO3Human RSPO3 Antibody (Rosmantuzumab, Research Use)NBR-0278
SetrusumabSclerostinHuman Sclerostin Antibody (Setrusumab, Research Use)NBR-0279
RomosozumabSclerostinHuman Sclerostin Antibody (Romosozumab, Research Use)NBR-0280
PepinemabSEMA4DHuman SEMA4D Antibody (Pepinemab, Research Use)NBR-0281
Hospital for Sick Children patent anti-SIRPASIRPAHuman SIRPA Antibody (Hospital for Sick Children patent anti-SIRPA, Research Use)NBR-0282
KWAR23SIRPGHuman SIRPG Antibody (KWAR23, Research Use)NBR-0283
BexmarilimabSTAB1Human STAB1 Antibody (Bexmarilimab, Research Use)NBR-0284
VandortuzumabSTEAP1Human STEAP1 Antibody (Vandortuzumab, Research Use)NBR-0285
IndatuximabSyndecan-1Human Syndecan-1 Antibody (Indatuximab, Research Use)NBR-0286
GosuranemabTauHuman Tau Antibody (Gosuranemab, Research Use)NBR-0287
SemorinemabTauHuman Tau Antibody (Semorinemab, Research Use)NBR-0288
TisotumabTFHuman TF Antibody (Tisotumab, Research Use)NBR-0289
SRK181TGFbHuman TGFb Antibody (SRK181, Research Use)NBR-0290
M7824TGFbHuman TGFb Antibody (M7824, Research Use)NBR-0291
SabatolimabTIM-3 / HAVCR2Human TIM-3 / HAVCR2 Antibody (Sabatolimab, Research Use)NBR-0292
TomaralimabTLR2Human TLR2 Antibody (Tomaralimab, Research Use)NBR-0293
C1068TLR3Human TLR3 Antibody (C1068, Research Use)NBR-0294
MapatumumabTRAIL-R1Human TRAIL-R1 Antibody (Mapatumumab, Research Use)NBR-0295
GBR 900TrkAHuman TrkA Antibody (GBR 900, Research Use)NBR-0296
SacituzumabTROP-2Human TROP-2 Antibody (Sacituzumab, Research Use)NBR-0297
EnavatuzumabTWEAKRHuman TWEAKR Antibody (Enavatuzumab, Research Use)NBR-0298
ELB031TYRO3Human TYRO3 Antibody (ELB031, Research Use)NBR-0299
TimolumabVAP-1Human VAP-1 Antibody (Timolumab, Research Use)NBR-0300
IcrucumabFLT1 / VEGFR1Human FLT1 / VEGFR1 Antibody (Icrucumab, Research Use)NBR-0301
DS-6000aCDH6Human CDH6 Antibody (DS-6000a, Research Use)NBR-0302
TabituximabFrizzled-10Human Frizzled-10 Antibody (Tabituximab, Research Use)NBR-0303
ItolizumabCD6Human CD6 Antibody (Itolizumab, Research Use)NBR-0304
Asclepius Technology patent anti-Robo1 CARRobo1Human Robo1 Antibody (Asclepius Technology patent anti-Robo1 CAR, Research Use)NBR-0305
MurlentamabAMHR2Human AMHR2 Antibody (Murlentamab, Research Use)NBR-0306
IdactamabASCT2Human ASCT2 Antibody (Idactamab, Research Use)NBR-0307
CarotuximabCD105Human CD105 Antibody (Carotuximab, Research Use)NBR-0308
Regeneron patent anti-CD48CD48Human CD48 Antibody (Regeneron patent anti-CD48, Research Use)NBR-0309
SC-005MelanotransferrinHuman Melanotransferrin Antibody (SC-005, Research Use)NBR-0310
IanalumabBAFFRHuman BAFFR Antibody (Ianalumab, Research Use)NBR-0311
GFB-024CB1Human CB1 Antibody (GFB-024, Research Use)NBR-0312
ErenumabCGRPRHuman CGRPR Antibody (Erenumab, Research Use)NBR-0313
GaradacimabFactor XIIHuman Factor XII Antibody (Garadacimab, Research Use)NBR-0314
BurosumabFGF23Human FGF23 Antibody (Burosumab, Research Use)NBR-0315
BMS-986012Fucosyl GM1Human Fucosyl GM1 Antibody (BMS-986012, Research Use)NBR-0316
AnifrolumabIFNAR-1Human IFNAR-1 Antibody (Anifrolumab, Research Use)NBR-0317
ARGX-112IL-22RAHuman IL-22RA Antibody (ARGX-112, Research Use)NBR-0318
DaxdilimabILT7Human ILT7 Antibody (Daxdilimab, Research Use)NBR-0319
LanadelumabKallikreinHuman Kallikrein Antibody (Lanadelumab, Research Use)NBR-0320
 OrticumaboxLDLHuman oxLDL Antibody ( Orticumab, Research Use)NBR-0321
CTX-2026ButyrophilinHuman Butyrophilin Antibody (CTX-2026, Research Use)NBR-0322
ARGX-117C2Human C2 Antibody (ARGX-117, Research Use)NBR-0323
NGM621C3Human C3 Antibody (NGM621, Research Use)NBR-0324
AtibuclimabCD14Human CD14 Antibody (Atibuclimab, Research Use)NBR-0325
AB-16B5ClusterinHuman Clusterin Antibody (AB-16B5, Research Use)NBR-0326
CSL324G-CSFHuman G-CSF Antibody (CSL324, Research Use)NBR-0327
DS-6157GPR20Human GPR20 Antibody (DS-6157, Research Use)NBR-0328
OS2966Integrin B1Human Integrin B1 Antibody (OS2966, Research Use)NBR-0329
NP137Netrin 1Human Netrin 1 Antibody (NP137, Research Use)NBR-0330
 BavituximabPhosphatidylserineHuman Phosphatidylserine Antibody ( Bavituximab, Research Use)NBR-0331
CSL346VEGFBHuman VEGFB Antibody (CSL346, Research Use)NBR-0332
GaretosmabActivin AHuman Activin A Antibody (Garetosmab, Research Use)NBR-0333
EnibarcimabAdrenomedullinHuman Adrenomedullin Antibody (Enibarcimab, Research Use)NBR-0334
ANX005C1qHuman C1q Antibody (ANX005, Research Use)NBR-0335
CSL311CSF2RBHuman CSF2RB Antibody (CSL311, Research Use)NBR-0336
NGM120GFRALHuman GFRAL Antibody (NGM120, Research Use)NBR-0337
GlenzocimabGPVIHuman GPVI Antibody (Glenzocimab, Research Use)NBR-0338
ATH3G10PhosphorylcholineHuman Phosphorylcholine Antibody (ATH3G10, Research Use)NBR-0339
M6495ADAMTS5Human ADAMTS5 Antibody (M6495, Research Use)NBR-0340
MK-6105IL-13RA1Human IL-13RA1  Antibody (MK-6105, Research Use)NBR-0341
BapotulimabILDR2Human ILDR2 Antibody (Bapotulimab, Research Use)NBR-0342
IndusatumabGCCHuman GCC Antibody (Indusatumab, Research Use)NBR-0343
STX-100Integrin AV & B6Human Integrin AV & B6 Antibody (STX-100, Research Use)NBR-0344
MilatuzumabMHCHuman MHC Antibody (Milatuzumab, Research Use)NBR-0345
 LifastuzumabNaPi2bHuman NaPi2b Antibody ( Lifastuzumab, Research Use)NBR-0346
MGD007A33Human A33 Antibody (MGD007, Research Use)NBR-0347
ApamistamabCD45Human CD45 Antibody (Apamistamab, Research Use)NBR-0348
EmicizumabFactor IXHuman Factor IX Antibody (Emicizumab, Research Use)NBR-0349
 VedolizumabIntegrin A4 & B7Human Integrin A4 & B7 Antibody ( Vedolizumab, Research Use)NBR-0350
MVT-5873Sialyl-Lewis AHuman Sialyl-Lewis A Antibody (MVT-5873, Research Use)NBR-0351
INSERM patent anti-vWFvWFHuman vWF Antibody (INSERM patent anti-vWF, Research Use)NBR-0352
Genzyme patent anti-CXCR3CXCR3Human CXCR3 Antibody (Genzyme patent anti-CXCR3, Research Use)NBR-0353
TA136TPORHuman TPOR Antibody (TA136, Research Use)NBR-0354
Genentech patent anti-Tryptase Beta 1TPSAB1Human TPSAB1 Antibody (Genentech patent anti-Tryptase Beta 1, Research Use)NBR-0355
Genentech patent anti-Bv8Bv8Human Bv8 Antibody (Genentech patent anti-Bv8, Research Use)NBR-0356
M116CCL17Human CCL17 Antibody (M116, Research Use)NBR-0357
KHK patent anti-CRTH2CRTh2Human CRTh2 Antibody (KHK patent anti-CRTH2, Research Use)NBR-0358
Cureab patent anti-GP73GP73Human GP73 Antibody (Cureab patent anti-GP73, Research Use)NBR-0359
Regeneron patent anti-GREM1GREM1Human GREM1 Antibody (Regeneron patent anti-GREM1, Research Use)NBR-0360
ErlizumabIntegrin B2Human Integrin B2 Antibody (Erlizumab, Research Use)NBR-0361
Abbott patent anti-NGRNGRHuman NGR Antibody (Abbott patent anti-NGR, Research Use)NBR-0362
Lilly patent anti-PACAPPACAP-38Human PACAP-38 Antibody (Lilly patent anti-PACAP, Research Use)NBR-0363
Novelmed patent anti-ProperdinProperdinHuman Properdin Antibody (Novelmed patent anti-Properdin, Research Use)NBR-0364
DISC-0974RGM CHuman RGM C Antibody (DISC-0974, Research Use)NBR-0365
Genentech patent anti-TAT226TAT226Human TAT226 Antibody (Genentech patent anti-TAT226, Research Use)NBR-0366
Regeneron patent anti-TMPRSS2 TMPRSS2Human TMPRSS2 Antibody (Regeneron patent anti-TMPRSS2 , Research Use)NBR-0367
Genentech patent anti-HGFA HGFAHuman HGFA Antibody (Genentech patent anti-HGFA , Research Use)NBR-0368
Chugai patent anti-HLA-DQ2HLA-DQ2Human HLA-DQ2 Antibody (Chugai patent anti-HLA-DQ2, Research Use)NBR-0369
Genentech patent anti-KLK5KLK5Human KLK5 Antibody (Genentech patent anti-KLK5, Research Use)NBR-0370
Amgen patent anti-ORAI1ORAI1Human ORAI1 Antibody (Amgen patent anti-ORAI1, Research Use)NBR-0371
Sanofi patent anti-PAI-1PAI-1Human PAI-1 Antibody (Sanofi patent anti-PAI-1, Research Use)NBR-0372
Novartis patent anti-PAR1PAR1Human PAR1 Antibody (Novartis patent anti-PAR1, Research Use)NBR-0373
U.Penn. patent anti-PF4PF4 / CXCL4Human PF4 / CXCL4 Antibody (U.Penn. patent anti-PF4, Research Use)NBR-0374
Multiple seq-one in animalPROKR1Human PROKR1 Antibody (Multiple seq-one in animal, Research Use)NBR-0375
Numab patent anti-HSASerum AlbuminHuman Serum Albumin Antibody (Numab patent anti-HSA, Research Use)NBR-0376
Genentech patent anti-STOP-1STOP-1Human STOP-1 Antibody (Genentech patent anti-STOP-1, Research Use)NBR-0377
Janssen patent anti-TMEFF2TENB2Human TENB2 Antibody (Janssen patent anti-TMEFF2, Research Use)NBR-0378
Regeneron patent anti-TIE-2TIE-2Human TIE-2 Antibody (Regeneron patent anti-TIE-2, Research Use)NBR-0379
Novartis patent anti-TMEM16A TMEM16AHuman TMEM16A Antibody (Novartis patent anti-TMEM16A , Research Use)NBR-0380
Genentech patent anti-PolyubiquitinPolyubiquitinHuman Polyubiquitin Antibody (Genentech patent anti-Polyubiquitin, Research Use)NBR-0381
Duke anti-NAv1.7Nav1.7Human Nav1.7 Antibody (Duke anti-NAv1.7, Research Use)NBR-0382
Genentech patent anti-Integrin  β7Integrin B7Human Integrin B7 Antibody (Genentech patent anti-Integrin  β7, Research Use)NBR-0383
Genentech patent anti-Jagged1JAG1Human JAG1 Antibody (Genentech patent anti-Jagged1, Research Use)NBR-0384
Regeneron patent anti-APLNRAPLNRHuman APLNR Antibody (Regeneron patent anti-APLNR, Research Use)NBR-0385
Immunomedics patent anti-Histone H2BHistone H2BHuman Histone H2B Antibody (Immunomedics patent anti-Histone H2B, Research Use)NBR-0386
Immunomedics patent anti-Histone H3Histone H3Human Histone H3 Antibody (Immunomedics patent anti-Histone H3, Research Use)NBR-0387
Immunomedics patent anti-Histone H4Histone H4Human Histone H4 Antibody (Immunomedics patent anti-Histone H4, Research Use)NBR-0388
19G9RG1Human RG1 Antibody (19G9, Research Use)NBR-0389
Regeneron patent anti-ANGPTL8ANGPTL8Human ANGPTL8 Antibody (Regeneron patent anti-ANGPTL8, Research Use)NBR-0390
Lilly patent anti-Pan-ELR+CXC-ELRHuman CXC-ELR Antibody (Lilly patent anti-Pan-ELR+, Research Use)NBR-0391
FHTR2163HtrA1Human HtrA1 Antibody (FHTR2163, Research Use)NBR-0392
Bayer patent anti-TIMP-1TIMP1Human TIMP1 Antibody (Bayer patent anti-TIMP-1, Research Use)NBR-0393
PF-06263507TPBGHuman TPBG Antibody (PF-06263507, Research Use)NBR-0394
OR2805CD163Human CD163 Antibody (OR2805, Research Use)NBR-0395
CanakinumabIL-1BHuman IL-1B Antibody (Canakinumab, Research Use)NBR-0396
LulizumabCD28Human CD28 Antibody (Lulizumab, Research Use)NBR-0397
RG7841Ly6EHuman Ly6E Antibody (RG7841, Research Use)NBR-0398
CRX-014TIM-1Human TIM-1 Antibody (CRX-014, Research Use)NBR-0399
OBI-833Globo HHuman Globo H Antibody (OBI-833, Research Use)NBR-0400
ADCT-901KAAG1Human KAAG1 Antibody (ADCT-901, Research Use)NBR-0401
KHK2898CD98Human CD98 Antibody (KHK2898, Research Use)NBR-0402
ATN-658uPARHuman uPAR Antibody (ATN-658, Research Use)NBR-0403
LIV-1205DLK-1Human DLK-1 Antibody (LIV-1205, Research Use)NBR-0404
OntuxizumabEndosialinHuman Endosialin Antibody (Ontuxizumab, Research Use)NBR-0405
Midwestern U. patent anti-ASPHHAAHHuman HAAH Antibody (Midwestern U. patent anti-ASPH, Research Use)NBR-0406
Oxford Bio patent anti-MatriptaseMatriptaseHuman Matriptase Antibody (Oxford Bio patent anti-Matriptase, Research Use)NBR-0407
Copenhagen Rigshospitalet patent anti-uPARAPMRC2Human MRC2 Antibody (Copenhagen Rigshospitalet patent anti-uPARAP, Research Use)NBR-0408
AG02-ADCPTGFRNHuman PTGFRN Antibody (AG02-ADC, Research Use)NBR-0409
Agensys patent anti-158P1D7158P1D7Human 158P1D7 Antibody (Agensys patent anti-158P1D7, Research Use)NBR-0410
Centrose patent anti-dysadherindysadherinHuman dysadherin Antibody (Centrose patent anti-dysadherin, Research Use)NBR-0411
Bluefin patent anti-TMEFF1TMEFF1Human TMEFF1 Antibody (Bluefin patent anti-TMEFF1, Research Use)NBR-0412
Regeneron patent anti-RETc-RETHuman c-RET Antibody (Regeneron patent anti-RET, Research Use)NBR-0413
CantuzumabC242Human C242 Antibody (Cantuzumab, Research Use)NBR-0414
TamrintamabDPEP3Human DPEP3 Antibody (Tamrintamab, Research Use)NBR-0415
BivatuzumabCD44v6Human CD44v6 Antibody (Bivatuzumab, Research Use)NBR-0416
 abituzumabIntegrin AVHuman Integrin AV Antibody ( abituzumab, Research Use)NBR-0417
Minomic patent anti-Glypican 1Glypican 1Human Glypican 1 Antibody (Minomic patent anti-Glypican 1, Research Use)NBR-0418
Scripps patent anti-CD11aIntegrin A11Human Integrin A11 Antibody (Scripps patent anti-CD11a, Research Use)NBR-0419
GlycoNex patent anti-Lewis Y / B Lewis Y / B antigenHuman Lewis Y / B antigen Antibody (GlycoNex patent anti-Lewis Y / B , Research Use)NBR-0420
MetuzumabBSG2Human BSG2 Antibody (Metuzumab, Research Use)NBR-0421
F16-IL2Tenascin CHuman Tenascin C Antibody (F16-IL2, Research Use)NBR-0422
INSERM patent anti-Glycophorin AGlycophorin AHuman Glycophorin A Antibody (INSERM patent anti-Glycophorin A, Research Use)NBR-0423
EcromeximabGD3Human GD3 Antibody (Ecromeximab, Research Use)NBR-0424
 PF-03732010P-cadherinHuman P-cadherin Antibody ( PF-03732010, Research Use)NBR-0425
RolinsatamabPRLRHuman PRLR Antibody (Rolinsatamab, Research Use)NBR-0426
CevostamabIRTA2Human IRTA2 Antibody (Cevostamab, Research Use)NBR-0427
DEDN6526AETB-RHuman ETB-R Antibody (DEDN6526A, Research Use)NBR-0428
SamrotamabLFL2Human LFL2 Antibody (Samrotamab, Research Use)NBR-0429
ASG-5MESLC44A4Human SLC44A4 Antibody (ASG-5ME, Research Use)NBR-0430
SirtratumabSLITRK6Human SLITRK6 Antibody (Sirtratumab, Research Use)NBR-0431
 SAR428926LAMP1Human LAMP1 Antibody ( SAR428926, Research Use)NBR-0432
PF-06647263EFNA4Human EFNA4 Antibody (PF-06647263, Research Use)NBR-0433
CusatuzumabCD27L / CD70Human CD27L / CD70 Antibody (Cusatuzumab, Research Use)NBR-0434
CDX-0158c-KitHuman c-Kit Antibody (CDX-0158, Research Use)NBR-0435
TarextumabNotch3Human Notch3 Antibody (Tarextumab, Research Use)NBR-0436
SGN-CD352ASLAMF6Human SLAMF6 Antibody (SGN-CD352A, Research Use)NBR-0437
LupartumabC4.4aHuman C4.4a Antibody (Lupartumab, Research Use)NBR-0438
IMMU-114HLA-DRHuman HLA-DR Antibody (IMMU-114, Research Use)NBR-0439
BlinatumomabCD3Human CD3 Antibody (Blinatumomab, Research Use)NBR-0440
SecukinumabIL-17Human IL-17 Antibody (Secukinumab, Research Use)NBR-0441
TralokinumabIL-13Human IL-13 Antibody (Tralokinumab, Research Use)NBR-0442
ZanolimumabCD4Human CD4 Antibody (Zanolimumab, Research Use)NBR-0443
Forerunner patent anti-DSG3DSG3Human DSG3 Antibody (Forerunner patent anti-DSG3, Research Use)NBR-0444
 AFM13FCgR3AHuman FCgR3A Antibody ( AFM13, Research Use)NBR-0445
JNJ-69086420KLK2Human KLK2 Antibody (JNJ-69086420, Research Use)NBR-0446
K1-70TSHRHuman TSHR Antibody (K1-70, Research Use)NBR-0447
Mellitus patent anti-CD59CD59Human CD59 Antibody (Mellitus patent anti-CD59, Research Use)NBR-0448
Zymogenetics patent anti-BCMA / TACIBCMA & TACIHuman BCMA & TACI Antibody (Zymogenetics patent anti-BCMA / TACI, Research Use)NBR-0449
TeplizumabCD3eHuman CD3e Antibody (Teplizumab, Research Use)NBR-0450
Argenx patent anti-MuSKMUSKHuman MUSK Antibody (Argenx patent anti-MuSK, Research Use)NBR-0451
CLN-619MICAHuman MICA Antibody (CLN-619, Research Use)NBR-0452
CDH17_A4CDH17Human CDH17 Antibody (CDH17_A4, Research Use)NBR-0453
EculizumabC5Human C5 Antibody (Eculizumab, Research Use)NBR-0454
PAR650097PAR-2Human PAR-2 Antibody (PAR650097, Research Use)NBR-0455
NadecnemabGFRA3Human GFRA3 Antibody (Nadecnemab, Research Use)NBR-0456
AtrosimabTNFRSF1AHuman TNFRSF1A Antibody (Atrosimab, Research Use)NBR-0457
PY159TREM-1Human TREM-1 Antibody (PY159, Research Use)NBR-0458
RG6125Cadherin-11Human Cadherin-11 Antibody (RG6125, Research Use)NBR-0459
Wuhan U. patent anti-Nav1.9Nav1.9Human Nav1.9 Antibody (Wuhan U. patent anti-Nav1.9, Research Use)NBR-0460
U.Tokyo patent anti-TLR7TLR7Human TLR7 Antibody (U.Tokyo patent anti-TLR7, Research Use)NBR-0461
LeronlimabCCR5Human CCR5 Antibody (Leronlimab, Research Use)NBR-0462
DrozitumabDR5 / TRAILR2Human DR5 / TRAILR2 Antibody (Drozitumab, Research Use)NBR-0463
MEN1309LY75Human LY75 / CD205 Antibody (MEN1309, Research Use)NBR-0464
AdalimumabTNFSF2Human TNFSF2 / TNFa Antibody (Adalimumab, Research Use)NBR-0465
HKT288CDH6Human CDH6 / K-Cadherin Antibody (HKT288, Research Use)NBR-0466
Genefrontier patent anti-CD69CD69Human CD69 Antibody (Genefrontier patent anti-CD69, Research Use)NBR-0467
Scripps Korea patent anti-CLEC14ACLEC14AHuman CLEC14A Antibody (Scripps Korea patent anti-CLEC14A, Research Use)NBR-0468
Oxford Bio patent anti-CRTAMCRTAMHuman CRTAM / CD355 Antibody (Oxford Bio patent anti-CRTAM, Research Use)NBR-0469
Med. Bio. Labs patent anti-CXADRCXADRHuman CXADR Antibody (Med. Bio. Labs patent anti-CXADR, Research Use)NBR-0470
Novimmune patent anti-CXCL9CXCL9Human CXCL9 Antibody (Novimmune patent anti-CXCL9, Research Use)NBR-0471
INSERM patent anti-DC-SIGNCD209Human DC-SIGN / CD209 Antibody (INSERM patent anti-DC-SIGN, Research Use)NBR-0472
Amgen patent anti-FerroportinSLC40A1Human SLC40A1 Antibody (Amgen patent anti-Ferroportin, Research Use)NBR-0473
CSL patent anti-G-CSFRCSF3RHuman CSF3R / G-CSFR Antibody (CSL patent anti-G-CSFR, Research Use)NBR-0474
KHK patent anti-HaptoglobinHaptoglobinHuman Haptoglobin Antibody (KHK patent anti-Haptoglobin, Research Use)NBR-0475
Wake Forest U. patent anti-IL-13RA2IL-13Ra2Human IL-13Ra2 / CD213a2 Antibody (Wake Forest U. patent anti-IL-13RA2, Research Use)NBR-0476
Cheng Kung U. patent anti-IL-20R1IL20RAHuman IL-20Ra Antibody (Cheng Kung U. patent anti-IL-20R1, Research Use)NBR-0477
EnokizumabIL-9Human IL-9 Antibody (Enokizumab, Research Use)NBR-0478
Innate patent anti-KIR2DLKIR2DL1Human KIR2DL1 / CD158a Antibody (Innate patent anti-KIR2DL, Research Use)NBR-0479
Novo Nordisk patent anti-PGLYRP1PGLYRP1Human PGLYRP1 / PGRP-S Antibody (Novo Nordisk patent anti-PGLYRP1, Research Use)NBR-0480
Diaccurate patent anti-sPLA2-GIBPLA2G1BHuman PLA2G1B Antibody (Diaccurate patent anti-sPLA2-GIB, Research Use)NBR-0481
Oncomed patent anti-RSPO1RSPO1Human RSPO1 Antibody (Oncomed patent anti-RSPO1, Research Use)NBR-0482
MapatumumabTNFRSF10AHuman TNFRSF10A / TRAILR1 / CD261 Antibody (Mapatumumab, Research Use)NBR-0483
Regeneron patent anti-CD48CD48Human CD48 Antibody (Regeneron patent anti-CD48, Research Use)NBR-0484
Regeneron patent anti-PROKR1PROKR1Human GPR73 / PROKR1 Antibody (Regeneron patent anti-PROKR1, Research Use)NBR-0485
Genentech patent anti-PolyubiquitinUBBHuman Polyubiquitin Antibody (Genentech patent anti-Polyubiquitin, Research Use)NBR-0486
SAR428926LAMP1Human LAMP1 / CD107a Antibody (SAR428926, Research Use)NBR-0487
Forerunner patent anti-DSG3DSG3Human DSG3 Antibody (Forerunner patent anti-DSG3, Research Use)NBR-0488
AFM13FcgR3aHuman FcgR3a / CD16a Antibody (AFM13, Research Use)NBR-0489
Mellitus patent anti-CD59CD59Human CD59 Antibody (Mellitus patent anti-CD59, Research Use)NBR-0490
SelicrelumabCD40Human TNFRSF5 / CD40 Antibody (Selicrelumab, Research Use)NBR-0491
DomagrozumabGDF8Human GDF8 / Myostatin Antibody (Domagrozumab, Research Use)NBR-0492
Abrilumab ITGA4 & ITGB7Human Integrin a4b7 (ITGA4 & ITGB7) Antibody (Abrilumab, Research Use)NBR-0493
AmlitelimabTNFSF4Human TNFSF4 / OX40L / CD252 Antibody (Amlitelimab, Research Use)NBR-0494
AbagovomabMUC16Human MUC16 Antibody (Abagovomab, Research Use)NBR-0495
Birtamimab SAA1Human Amyloid Alpha Antibody (Birtamimab, Research Use)NBR-0496
Aducanumab APPHuman Amyloid Beta Antibody (Aducanumab, Research Use)NBR-0497
Abbott patent anti-Flt1VEGFR1Human VEGFR1 / FLT1 Antibody (Abbott patent anti-Flt1, Research Use)NBR-0498
Crenezumab APPHuman Amyloid Beta Antibody (Crenezumab, Research Use)NBR-0499
DLX212 APPHuman Amyloid Beta Antibody (DLX212, Research Use)NBR-0500
Acceleron patent anti-ActRIIBACVR2BHuman ACVR2B Antibody (Acceleron patent anti-ActRIIB, Research Use)NBR-0501
Gantenerumab APPHuman Amyloid Beta Antibody (Gantenerumab, Research Use)NBR-0502
ActoxumabN/AHuman Cdiff Toxin A Antibody (Actoxumab, Research Use)NBR-0503
GSK 933776 APPHuman Amyloid Beta Antibody (GSK 933776, Research Use)NBR-0504
Ajinomoto patent anti-vWFvWFHuman vWF Antibody (Ajinomoto patent anti-vWF, Research Use)NBR-0505
AlomfilimabICOSHuman ICOS / CD278 Antibody (Alomfilimab, Research Use)NBR-0506
Amgen patent anti-beta amyloid APPHuman Amyloid Beta Antibody (Amgen patent anti-beta amyloid, Research Use)NBR-0507
MEDI3617ANGPT2Human ANGPT2 Antibody (MEDI3617, Research Use)NBR-0508
ApitegromabGDF8Human GDF8 / Myostatin Antibody (Apitegromab, Research Use)NBR-0509
ZansecimabANGPT2Human ANGPT2 Antibody (Zansecimab, Research Use)NBR-0510
Nanyang Tech.U. patent anti-ANGPTL4ANGPTL4Human ANGPTL4 Antibody (Nanyang Tech.U. patent anti-ANGPTL4, Research Use)NBR-0511
AstegolimabIL-1RL1Human IL-1RL1 / ST2 / IL-33R Antibody (Astegolimab, Research Use)NBR-0512
Avdoralimab C5AR1Human Complement C5aR1 Antibody (Avdoralimab, Research Use)NBR-0513
Aveo anti-RONMST1RHuman MSPR / RON / CD136 Antibody (Aveo anti-RON, Research Use)NBR-0514
MipasetamAbAXLHuman AXL / UFO Antibody (MipasetamAb, Research Use)NBR-0515
AdebrelimabCD274Human B7-H1 / PD-L1 / CD274 Antibody (Adebrelimab, Research Use)NBR-0516
BatoclimabFCGRTHuman FcRn (FCGRT & B2M) Antibody (Batoclimab, Research Use)NBR-0517
Baylor patent anti-IFN alphaIFNa1Human IFNa1 Antibody (Baylor patent anti-IFN alpha, Research Use)NBR-0518
Garivulimab CD274Human B7-H1 / PD-L1 / CD274 Antibody (Garivulimab, Research Use)NBR-0519
Befovacimab TFPIHuman TFPI Antibody (Befovacimab, Research Use)NBR-0520
Manelimab CD274Human B7-H1 / PD-L1 / CD274 Antibody (Manelimab, Research Use)NBR-0521
BegelomabDPP4Human DPP4 / CD26 Antibody (Begelomab, Research Use)NBR-0522
Pacmilimab CD274Human B7-H1 / PD-L1 / CD274 Antibody (Pacmilimab, Research Use)NBR-0523
Sudubrilimab CD274Human B7-H1 / PD-L1 / CD274 Antibody (Sudubrilimab, Research Use)NBR-0524
Sugemalimab CD274Human B7-H1 / PD-L1 / CD274 Antibody (Sugemalimab, Research Use)NBR-0525
PrezalumabICOSLGHuman B7-H2 / ICOSL / CD275 Antibody (Prezalumab, Research Use)NBR-0526
Trellis patent anti-B7-H3CD276Human B7-H3 / CD276 Antibody (Trellis patent anti-B7-H3, Research Use)NBR-0527
Millennium patent anti-B7-H4 VTCN1Human B7-H4 / VTCN1 Antibody (Millennium patent anti-B7-H4, Research Use)NBR-0528
Genentech anti-BACE1BACE1Human BACE1 Antibody (Genentech anti-BACE1, Research Use)NBR-0529
Blosozumab SOSTHuman SOST / Sclerostin Antibody (Blosozumab, Research Use)NBR-0530
BococizumabPCSK9Human PCSK9 Antibody (Bococizumab, Research Use)NBR-0531
Boehringer anti-PCSK9PCSK9Human PCSK9 Antibody (Boehringer anti-PCSK9, Research Use)NBR-0532
Eptinezumab CALCAHuman CALCA / CGRP Antibody (Eptinezumab, Research Use)NBR-0533
Fremanezumab CALCAHuman CALCA / CGRP Antibody (Fremanezumab, Research Use)NBR-0534
Galcanezumab CALCAHuman CALCA / CGRP Antibody (Galcanezumab, Research Use)NBR-0535
Brigham and Women's patent anti-ABCB5 ABCB5Human ABCB5 Antibody (Brigham and Women's patent anti-ABCB5, Research Use)NBR-0536
NimacimabCNR1Human CB1 / CNR1 Antibody (Nimacimab, Research Use)NBR-0537
CarlumabCCL2Human CCL2 / MCP1 Antibody (Carlumab, Research Use)NBR-0538
NI-0701 CCL5Human CCL5 / RANTES Antibody (NI-0701, Research Use)NBR-0539
Pierre Fabre patent anti-CD151CD151Human CD151 Antibody (Pierre Fabre patent anti-CD151, Research Use)NBR-0540
Centocor patent anti-CD147BSGHuman EMMPRIN / CD147 Antibody (Centocor patent anti-CD147, Research Use)NBR-0541
DenintuzumabCD19Human CD19 Antibody (Denintuzumab, Research Use)NBR-0542
Duke U. patent anti-CD19CD19Human CD19 Antibody (Duke U. patent anti-CD19, Research Use)NBR-0543
Centocor patent anti-IL-25IL25Human IL-25 Antibody (Centocor patent anti-IL-25, Research Use)NBR-0544
CertolizumAbTNFSF2Human TNFSF2 / TNFa Antibody (CertolizumAb, Research Use)NBR-0545
SiplizumabCD2Human CD2 Antibody (Siplizumab, Research Use)NBR-0546
Chinese CDC patent anti-Interferon AlphaIFNA1Human IFNa1 Antibody (Chinese CDC patent anti-Interferon Alpha, Research Use)NBR-0547
CNTO 2125 APPHuman Amyloid Beta Antibody (CNTO 2125, Research Use)NBR-0548
CNTO 607 IL13Human IL-13 Antibody (CNTO 607, Research Use)NBR-0549
CNTO5429TLR3Human TLR3 / CD283 Antibody (CNTO5429, Research Use)NBR-0550
Cobolimab HAVCR2Human TIM-3 / HAVCR2 / CD366 Antibody (Cobolimab, Research Use)NBR-0551
CofetuzumabPTK7Human PTK7 / CCK4 Antibody (Cofetuzumab, Research Use)NBR-0552
Coltuximab CD19Human CD19 Antibody (Coltuximab, Research Use)NBR-0553
Concizumab TFPIHuman TFPI Antibody (Concizumab, Research Use)NBR-0554
RipertamabCD20Human CD20 Antibody (Ripertamab, Research Use)NBR-0555
TRU-015CD20Human CD20 Antibody (TRU-015, Research Use)NBR-0556
UblituximabCD20Human CD20 Antibody (Ublituximab, Research Use)NBR-0557
VeltuzumabCD20Human CD20 Antibody (Veltuzumab, Research Use)NBR-0558
ZuberitamabCD20Human CD20 Antibody (Zuberitamab, Research Use)NBR-0559
FR104CD28Human CD28 Antibody (FR104, Research Use)NBR-0560
GaliximabCD80Human CD28L / CD80 Antibody (Galiximab, Research Use)NBR-0561
CoprelotamabERBB2Human ERBB2 / HER2 / CD340 Antibody (Coprelotamab, Research Use)NBR-0562
Cosibelimab CD274Human B7-H1 / PD-L1 / CD274 Antibody (Cosibelimab, Research Use)NBR-0563
CrovalimabC5Human Complement C5 Antibody (Crovalimab, Research Use)NBR-0564
CSIRO anti-amyloid Beta scFv APPHuman Amyloid Beta Antibody (CSIRO anti-amyloid Beta scFv, Research Use)NBR-0565
CudarolimabTNFRSF4Human TNFRSF4 / OX40 / CD134 Antibody (Cudarolimab, Research Use)NBR-0566
DalotuzumabIGF1RHuman IGF1R / CD221 Antibody (Dalotuzumab, Research Use)NBR-0567
DapirolizumabCD40LGHuman TNFSF5 / CD40L / CD154 Antibody (Dapirolizumab, Research Use)NBR-0568
Visilizumab CD3EHuman CD3 Antibody (Visilizumab, Research Use)NBR-0569
ITRI patent anti-CD34CD34Human CD34 Antibody (ITRI patent anti-CD34, Research Use)NBR-0570
FelzartamabCD38Human CD38 Antibody (Felzartamab, Research Use)NBR-0571
IsatuximabCD38Human CD38 Antibody (Isatuximab, Research Use)NBR-0572
MezagitamabCD38Human CD38 Antibody (Mezagitamab, Research Use)NBR-0573
IbalizumabCD4Human CD4 Antibody (Ibalizumab, Research Use)NBR-0574
TregalizumabCD4Human CD4 Antibody (Tregalizumab, Research Use)NBR-0575
TRX1CD4Human CD4 Antibody (TRX1, Research Use)NBR-0576
DepemokimabIL-5Human IL-5 Antibody (Depemokimab, Research Use)NBR-0577
DerlotuximabH1-0Human Histone H1 Antibody (Derlotuximab, Research Use)NBR-0578
DivozilimabCD20Human CD20 Antibody (Divozilimab, Research Use)NBR-0579
LetaplimabCD47Human CD47 Antibody (Letaplimab, Research Use)NBR-0580
LigufalimabCD47Human CD47 Antibody (Ligufalimab, Research Use)NBR-0581
LintuzumAbCD33Human Siglec-3 / CD33 Antibody (LintuzumAb, Research Use)NBR-0582
UrabrelimabCD47Human CD47 Antibody (Urabrelimab, Research Use)NBR-0583
Domantis patent anti-VEGFVEGFHuman VEGF Antibody (Domantis patent anti-VEGF, Research Use)NBR-0584
Dompe patent anti-FOLR1FOLR1Human FOLR1 Antibody (Dompe patent anti-FOLR1, Research Use)NBR-0585
GatralimabCD52Human CD52 Antibody (Gatralimab, Research Use)NBR-0586
Quark patent anti-CD59CD59Human CD59 Antibody (Quark patent anti-CD59, Research Use)NBR-0587
DomvanalimabTIGITHuman TIGIT Antibody (Domvanalimab, Research Use)NBR-0588
DonanemabAmyloid BetaHuman Amyloid Beta Antibody (Donanemab, Research Use)NBR-0589
GrisnilimAbCD7Human CD7 Antibody (GrisnilimAb, Research Use)NBR-0590
DostarlimabCD279Human PDCD1 / PD-1 / CD279 Antibody (Dostarlimab, Research Use)NBR-0591
IladatuzumAbCD79bHuman CD79b Antibody (IladatuzumAb, Research Use)NBR-0592
Genentech patent anti-CD83CD83Human CD83 Antibody (Genentech patent anti-CD83, Research Use)NBR-0593
Genentech patent anti-CD9CD9Human CD9 Antibody (Genentech patent anti-CD9, Research Use)NBR-0594
Stem Centrx patent anti-Cadherin-1CD324Human CDH1 / E-cadherin / CD324 Antibody (Stem Centrx patent anti-Cadherin-1, Research Use)NBR-0595
PF-03732010CDH3Human CDH3 / P-cadherin Antibody (PF-03732010, Research Use)NBR-0596
Chaim Sheba Med. Cntr. patent anti-CEACAM1CD66aHuman CEACAM1 / CD66a Antibody (Chaim Sheba Med. Cntr. patent anti-CEACAM1, Research Use)NBR-0597
CergutuzumAbCD66eHuman CEACAM5 / CEA / CD66e Antibody (CergutuzumAb, Research Use)NBR-0598
EbdarokimabIL-12bHuman IL-12b Antibody (Ebdarokimab, Research Use)NBR-0599
TusamitamabCD66eHuman CEACAM5 / CEA / CD66e Antibody (Tusamitamab, Research Use)NBR-0600
EbronucimabPCSK9Human PCSK9 Antibody (Ebronucimab, Research Use)NBR-0601
TinurilimabCD66cHuman CEACAM6 / CD66c Antibody (Tinurilimab, Research Use)NBR-0602
Academia Sinica patent anti-Clathrin Heavy ChainCHCHuman Clathrin Heavy Chain / CHC Antibody (Academia Sinica patent anti-Clathrin Heavy Chain, Research Use)NBR-0603
ElsilimomabIL-6Human IL-6 / IFNb2 Antibody (Elsilimomab, Research Use)NBR-0604
Emory U. anti-CD40CD40Human TNFRSF5 / CD40 Antibody (Emory U. anti-CD40, Research Use)NBR-0605
BIIB059CLEC4CHuman CLEC4C Antibody (BIIB059, Research Use)NBR-0606
LendalizumabComplement C5Human Complement C5 Antibody (Lendalizumab, Research Use)NBR-0607
RavulizumabComplement C5Human Complement C5 Antibody (Ravulizumab, Research Use)NBR-0608
EnoticumabDLL4Human DLL4 Antibody (Enoticumab, Research Use)NBR-0609
G2 patent anti-C5aRComplement C5aR1Human Complement C5aR1 Antibody (G2 patent anti-C5aR, Research Use)NBR-0610
LampalizumabComplement Factor DHuman Complement Factor D Antibody (Lampalizumab, Research Use)NBR-0611
Epitomics patent anti-TNFαTNFSF2Human TNFSF2 / TNFa Antibody (Epitomics patent anti-TNFα, Research Use)NBR-0612
EmactuzumabCSF1RHuman CSF1R / M-CSFR / CD115 Antibody (Emactuzumab, Research Use)NBR-0613
LY3022855CSF1RHuman CSF1R / M-CSFR / CD115 Antibody (LY3022855, Research Use)NBR-0614
GimsilumabCSF2Human CSF2 / GM-CSF Antibody (Gimsilumab, Research Use)NBR-0615
LenzilumabCSF2Human CSF2 / GM-CSF Antibody (Lenzilumab, Research Use)NBR-0616
NamilumabCSF2Human CSF2 / GM-CSF Antibody (Namilumab, Research Use)NBR-0617
Etrolizumab ITGA4 & ITGB7Human Integrin a4b7 (ITGA4 & ITGB7) Antibody (Etrolizumab, Research Use)NBR-0618
EvolocumabPCSK9Human PCSK9 Antibody (Evolocumab, Research Use)NBR-0619
Expression DD patent anti-SIPSphingosine-1-phosphateHuman Sphingosine-1-phosphate Antibody (Expression DD patent anti-SIP, Research Use)NBR-0620
FinotonlimabCD279Human PDCD1 / PD-1 / CD279 Antibody (Finotonlimab, Research Use)NBR-0621
FlanvotumabTRP1Human TRP1 / TYRP1 Antibody (Flanvotumab, Research Use)NBR-0622
NurulimabCD152Human CTLA-4 / CD152  Antibody (Nurulimab, Research Use)NBR-0623
TremelimumabCD152Human CTLA-4 / CD152  Antibody (Tremelimumab, Research Use)NBR-0624
ZalifrelimabCD152Human CTLA-4 / CD152  Antibody (Zalifrelimab, Research Use)NBR-0625
CAT-2200CTLA-8Human CTLA-8 / IL-17a Antibody (CAT-2200, Research Use)NBR-0626
IxekizumabCTLA-8Human CTLA-8 / IL-17a Antibody (Ixekizumab, Research Use)NBR-0627
NetakimabCTLA-8Human CTLA-8 / IL-17a Antibody (Netakimab, Research Use)NBR-0628
PerakizumabCTLA-8Human CTLA-8 / IL-17a Antibody (Perakizumab, Research Use)NBR-0629
UCB patent anti-IL-17CTLA-8Human CTLA-8 / IL-17a Antibody (UCB patent anti-IL-17, Research Use)NBR-0630
VunakizumabCTLA-8Human CTLA-8 / IL-17a Antibody (Vunakizumab, Research Use)NBR-0631
FontolizumabIFNgHuman IFNg Antibody (Fontolizumab, Research Use)NBR-0632
NI-0801CXCL10Human CXCL10 / IP-10 Antibody (NI-0801, Research Use)NBR-0633
Genentech anti-CXCL12CXCL12Human CXCL12 / SDF1a Antibody (Genentech anti-CXCL12, Research Use)NBR-0634
ABX-IL8CXCL8Human CXCL8 / IL-8 Antibody (ABX-IL8, Research Use)NBR-0635
Genentech patent anti-IL-8CXCL8Human CXCL8 / IL-8 Antibody (Genentech patent anti-IL-8, Research Use)NBR-0636
ForalumabCD3eHuman CD3e Antibody (Foralumab, Research Use)NBR-0637
Dana-Farber patent anti-CXCR4 CXCR4Human CXCR4 / CD184 Antibody (Dana-Farber patent anti-CXCR4, Research Use)NBR-0638
Forerunner patent anti-ICAM-3ICAM3Human ICAM3 / CD50 Antibody (Forerunner patent anti-ICAM-3, Research Use)NBR-0639
Forerunner patent anti-Muc 17MUC17Human MUC17 Antibody (Forerunner patent anti-Muc 17, Research Use)NBR-0640
Fox Chase patent anti-TEM7R PLXDC2Human TEM7R / PLXDC2 Antibody (Fox Chase patent anti-TEM7R, Research Use)NBR-0641
FresolimumabTGFB1Human TGFb1 Antibody (Fresolimumab, Research Use)NBR-0642
FrovocimabPCSK9Human PCSK9 Antibody (Frovocimab, Research Use)NBR-0643
Smart Targeting patent anti-DLL4 DLL4Human DLL4 Antibody (Smart Targeting patent anti-DLL4, Research Use)NBR-0644
GancotamabERBB2Human ERBB2 / HER2 / CD340 Antibody (Gancotamab, Research Use)NBR-0645
Gatipotuzumab MUC1Human MUC1 Antibody (Gatipotuzumab, Research Use)NBR-0646
ParsatuzumabEGFL7Human EGFL7 Antibody (Parsatuzumab, Research Use)NBR-0647
Genentech patent anti-Factor BCFBHuman Complement Factor B Antibody (Genentech patent anti-Factor B, Research Use)NBR-0648
Genentech patent anti-Notch3NOTCH3Human NOTCH3 Antibody (Genentech patent anti-Notch3, Research Use)NBR-0649
Adecatumumab EPCAMHuman EpCAM / TROP1 / CD326 Antibody (Adecatumumab, Research Use)NBR-0650
Georgetown U. patent anti-Amyloid Beta APPHuman Amyloid Beta Antibody (Georgetown U. patent anti-Amyloid Beta, Research Use)NBR-0651
GeptanolimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Geptanolimab, Research Use)NBR-0652
GevokizumabIL-1bHuman IL-1b Antibody (Gevokizumab, Research Use)NBR-0653
GiloralimabCD40Human TNFRSF5 / CD40 Antibody (Giloralimab, Research Use)NBR-0654
7A7ERBB1Human ERBB1 / EGFR / HER1 Antibody (7A7, Research Use)NBR-0655
Chinese Mil.Med.Sci. patent anti-EGFRERBB1Human ERBB1 / EGFR / HER1 Antibody (Chinese Mil.Med.Sci. patent anti-EGFR, Research Use)NBR-0656
DemupitamabERBB1Human ERBB1 / EGFR / HER1 Antibody (Demupitamab, Research Use)NBR-0657
DepatuxizumabERBB1Human ERBB1 / EGFR / HER1 Antibody (Depatuxizumab, Research Use)NBR-0658
Duke D2C7ERBB1Human ERBB1 / EGFR / HER1 Antibody (Duke D2C7, Research Use)NBR-0659
ImgatuzumabERBB1Human ERBB1 / EGFR / HER1 Antibody (Imgatuzumab, Research Use)NBR-0660
LaprituximAbERBB1Human ERBB1 / EGFR / HER1 Antibody (LaprituximAb, Research Use)NBR-0661
MatuzumabERBB1Human ERBB1 / EGFR / HER1 Antibody (Matuzumab, Research Use)NBR-0662
NecitumumabERBB1Human ERBB1 / EGFR / HER1 Antibody (Necitumumab, Research Use)NBR-0663
GolimumabTNFSF2Human TNFSF2 / TNFa Antibody (Golimumab, Research Use)NBR-0664
PimurutamabERBB1Human ERBB1 / EGFR / HER1 Antibody (Pimurutamab, Research Use)NBR-0665
Shanghai Cancer Inst patent anti-EGFRvIIIERBB1Human ERBB1 / EGFR / HER1 Antibody (Shanghai Cancer Inst patent anti-EGFRvIII, Research Use)NBR-0666
ZalutumumabERBB1Human ERBB1 / EGFR / HER1 Antibody (Zalutumumab, Research Use)NBR-0667
IbritumomabCD20Human CD20 Antibody (Ibritumomab, Research Use)NBR-0668
IcatolimabBTLAHuman BTLA / CD272 Antibody (Icatolimab, Research Use)NBR-0669
IfabotuzumabEphA3Human EphA3 Antibody (Ifabotuzumab, Research Use)NBR-0670
HersintuzumabERBB2Human ERBB2 / HER2 / CD340 Antibody (Hersintuzumab, Research Use)NBR-0671
MargetuximabERBB2Human ERBB2 / HER2 / CD340 Antibody (Margetuximab, Research Use)NBR-0672
TimigutuzumabERBB2Human ERBB2 / HER2 / CD340 Antibody (Timigutuzumab, Research Use)NBR-0673
BarecetamabERBB3Human ERBB3 / HER3 Antibody (Barecetamab, Research Use)NBR-0674
LumretuzumabERBB3Human ERBB3 / HER3 Antibody (Lumretuzumab, Research Use)NBR-0675
Imclone 6.64KDRHuman VEGFR2 / KDR / CD309 Antibody (Imclone 6.64, Research Use)NBR-0676
Immunomedics hA19CD19Human CD19 Antibody (Immunomedics hA19, Research Use)NBR-0677
AbelacimabF11Human F11 / Factor XI Antibody (Abelacimab, Research Use)NBR-0678
LumiliximabFCER2Human FceR2 / CD23 Antibody (Lumiliximab, Research Use)NBR-0679
DFRF4539AFcRL5Human FcRL5 / IRTA2 Antibody (DFRF4539A, Research Use)NBR-0680
Immunomedics patent anti-IGF-1RIGF1RHuman IGF1R / CD221 Antibody (Immunomedics patent anti-IGF-1R, Research Use)NBR-0681
Imperial College anti-DDR1DDR1Human DDR1 / CD167a Antibody (Imperial College anti-DDR1, Research Use)NBR-0682
Lilly patent anti-FGFR-1FGFR1Human FGFR1 / CD331 Antibody (Lilly patent anti-FGFR-1, Research Use)NBR-0683
INSERM patent anti-CO-029TSPAN8Human TSPAN8 Antibody (INSERM patent anti-CO-029, Research Use)NBR-0684
RadretumabFN1Human Fibronectin Antibody (Radretumab, Research Use)NBR-0685
PelgifatamAbFOLH1 Human FOLH1 / PSMA Antibody (PelgifatamAb, Research Use)NBR-0686
IparomlimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Iparomlimab, Research Use)NBR-0687
VantictumabFZDHuman FZD Antibody (Vantictumab, Research Use)NBR-0688
IvuxolimabTNFRSF4Human TNFRSF4 / OX40 / CD134 Antibody (Ivuxolimab, Research Use)NBR-0689
Jackson Foundation patent anti-ERGERGHuman ERG Antibody (Jackson Foundation patent anti-ERG, Research Use)NBR-0690
DinutuximabN/AHuman GD2 Antibody (Dinutuximab, Research Use)NBR-0691
EMD 273063N/AHuman GD2 Antibody (EMD 273063, Research Use)NBR-0692
Korea Natl.Cancer Ctr. patent anti-GITRTNFRSF18Human TNFRSF18 / GITR / CD357 Antibody (Korea Natl.Cancer Ctr. patent anti-GITR, Research Use)NBR-0693
Korea RIBB patent anti-cMetMETHuman HGFR / c-Met Antibody (Korea RIBB patent anti-cMet, Research Use)NBR-0694
Kumamoto U. patent anti-Amyloid Beta APPHuman Amyloid Beta Antibody (Kumamoto U. patent anti-Amyloid Beta, Research Use)NBR-0695
LatozinemabSORT1Human Sortilin / SORT1 Antibody (Latozinemab, Research Use)NBR-0696
LemzoparlimabCD47Human CD47 Antibody (Lemzoparlimab, Research Use)NBR-0697
LilotomabCD37Human TSPAN26 / CD37 Antibody (Lilotomab, Research Use)NBR-0698
Lodapolimab CD274Human B7-H1 / PD-L1 / CD274 Antibody (Lodapolimab, Research Use)NBR-0699
LodelcizumabPCSK9Human PCSK9 Antibody (Lodelcizumab, Research Use)NBR-0700
Facet patent anti-GPR64ADGRG2Human GPR64 / ADGRG2 Antibody (Facet patent anti-GPR64, Research Use)NBR-0701
LonigutamAbIGF1RHuman IGF1R / CD221 Antibody (LonigutamAb, Research Use)NBR-0702
LosatuxizumAbERBB1Human ERBB1 / EGFR / HER1 Antibody (LosatuxizumAb, Research Use)NBR-0703
Ludwig-Maximilians U. anti_HepsinHAMP Human Hepcidin / HAMP Antibody (Ludwig-Maximilians U. anti_Hepsin, Research Use)NBR-0704
LY2787106HAMP Human Hepcidin / HAMP Antibody (LY2787106, Research Use)NBR-0705
Macrogenics patent anti-KID3KID3Human KID3 Antibody (Macrogenics patent anti-KID3, Research Use)NBR-0706
TAK-701HGFHuman HGF / SF Antibody (TAK-701, Research Use)NBR-0707
Metheresis patent anti-MetMETHuman HGFR / c-Met Antibody (Metheresis patent anti-Met, Research Use)NBR-0708
SAIT301METHuman HGFR / c-Met Antibody (SAIT301, Research Use)NBR-0709
Merck anti-Amyloid beta 19.3 APPHuman Amyloid Beta Antibody (Merck anti-Amyloid beta 19.3, Research Use)NBR-0710
Merck patent anti-Amyloid Beta APPHuman Amyloid Beta Antibody (Merck patent anti-Amyloid Beta, Research Use)NBR-0711
MirzotamAbCD276Human B7-H3 / CD276 Antibody (MirzotamAb, Research Use)NBR-0712
ModotuximabERBB1Human ERBB1 / EGFR / HER1 Antibody (Modotuximab, Research Use)NBR-0713
BersanlimabICAM1Human ICAM1 / CD54 Antibody (Bersanlimab, Research Use)NBR-0714
MEDI-570ICOSHuman ICOS / CD278 Antibody (MEDI-570, Research Use)NBR-0715
AMG 811IFNgHuman IFNg Antibody (AMG 811, Research Use)NBR-0716
EmapalumabIFNgHuman IFNg Antibody (Emapalumab, Research Use)NBR-0717
QuilizumabIGHEHuman IgE (M1 prime) Antibody (Quilizumab, Research Use)NBR-0718
LigelizumabIGHEHuman IgE Antibody (Ligelizumab, Research Use)NBR-0719
MupadolimabNT5EHuman NT5E / CD73 Antibody (Mupadolimab, Research Use)NBR-0720
TalizumabIGHEHuman IgE Antibody (Talizumab, Research Use)NBR-0721
NaptumomAbTPBGHuman TPBG Antibody (NaptumomAb, Research Use)NBR-0722
FigitumumabIGF1RHuman IGF1R / CD221 Antibody (Figitumumab, Research Use)NBR-0723
GanitumabIGF1RHuman IGF1R / CD221 Antibody (Ganitumab, Research Use)NBR-0724
NIH patent anti-MesothelinMSLNHuman Mesothelin Antibody (NIH patent anti-Mesothelin, Research Use)NBR-0725
NimotuzumabERBB1Human ERBB1 / EGFR / HER1 Antibody (Nimotuzumab, Research Use)NBR-0726
DX-2647IGF2Human IGF2 Antibody (DX-2647, Research Use)NBR-0727
BT-063IL-10Human IL-10 Antibody (BT-063, Research Use)NBR-0728
BriakinumabIL-12aHuman IL-12 (IL-12a & IL-12b) Antibody (Briakinumab, Research Use)NBR-0729
NipocalimabFcRnHuman FcRn (FCGRT & B2M) Antibody (Nipocalimab, Research Use)NBR-0730
AbrezekimabIL-13Human IL-13 Antibody (Abrezekimab, Research Use)NBR-0731
CendakimabIL-13Human IL-13 Antibody (Cendakimab, Research Use)NBR-0732
DectrekumabIL-13Human IL-13 Antibody (Dectrekumab, Research Use)NBR-0733
GSK 679586IL-13Human IL-13 Antibody (GSK 679586, Research Use)NBR-0734
H2L6IL-13Human IL-13 Antibody (H2L6, Research Use)NBR-0735
IMA-026IL-13Human IL-13 Antibody (IMA-026, Research Use)NBR-0736
LebrikizumabIL-13Human IL-13 Antibody (Lebrikizumab, Research Use)NBR-0737
M1295IL-13Human IL-13 Antibody (M1295, Research Use)NBR-0738
NofazinlimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Nofazinlimab, Research Use)NBR-0739
Novartis patent anti-CD45PTPRCHuman PTPRC / CD45 Antibody (Novartis patent anti-CD45, Research Use)NBR-0740
DISC0280IL-15Human IL-15 Antibody (DISC0280, Research Use)NBR-0741
ABT-325IL-18Human IL-18 Antibody (ABT-325, Research Use)NBR-0742
BermekimabIL-1aHuman IL-1a Antibody (Bermekimab, Research Use)NBR-0743
CDP484IL-1bHuman IL-1b Antibody (CDP484, Research Use)NBR-0744
Novo Nordisk patent anti-Factor VIIIF8Human F8 / Factor VIII Antibody (Novo Nordisk patent anti-Factor VIII, Research Use)NBR-0745
MelrilimabIL-1RL1Human IL-1RL1 / ST2 / IL-33R Antibody (Melrilimab, Research Use)NBR-0746
Cheng Kung U. patent anti-IL-20IL-20Human IL-20 Antibody (Cheng Kung U. patent anti-IL-20, Research Use)NBR-0747
AvizakimabIL-21Human IL-21 Antibody (Avizakimab, Research Use)NBR-0748
BrazikumabIL-23Human IL-23 Antibody (Brazikumab, Research Use)NBR-0749
LY2525623IL-23Human IL-23 Antibody (LY2525623, Research Use)NBR-0750
MirikizumabIL-23Human IL-23 Antibody (Mirikizumab, Research Use)NBR-0751
RisankizumabIL-23Human IL-23a Antibody (Risankizumab, Research Use)NBR-0752
CamidanlumAbIL-2RaHuman IL-2Ra / CD25 Antibody (CamidanlumAb, Research Use)NBR-0753
OcaratuzumabCD20Human CD20 Antibody (Ocaratuzumab, Research Use)NBR-0754
OciperlimabTIGITHuman TIGIT Antibody (Ociperlimab, Research Use)NBR-0755
OcrelizumabCD20Human CD20 Antibody (Ocrelizumab, Research Use)NBR-0756
ItepekimabIL-33Human IL-33 Antibody (Itepekimab, Research Use)NBR-0757
OfatumumabCD20Human CD20 Antibody (Ofatumumab, Research Use)NBR-0758
MEDI2045IL-4RaHuman IL-4Ra / CD124 Antibody (MEDI2045, Research Use)NBR-0759
Abgenix anti-IL-5IL-5Human IL-5 Antibody (Abgenix anti-IL-5, Research Use)NBR-0760
Okayama U. patent anti-oxLDLOLR1Human oxLDL Antibody (Okayama U. patent anti-oxLDL, Research Use)NBR-0761
Chugai SK2IL-6Human IL-6 / IFNb2 Antibody (Chugai SK2, Research Use)NBR-0762
CSTRI patent anti-IL-6IL-6Human IL-6 / IFNb2 Antibody (CSTRI patent anti-IL-6, Research Use)NBR-0763
Medarex patent anti-IL-6IL-6Human IL-6 / IFNb2 Antibody (Medarex patent anti-IL-6, Research Use)NBR-0764
MEDI 5117IL-6Human IL-6 / IFNb2 Antibody (MEDI 5117, Research Use)NBR-0765
Merck patent anti-IL-6IL-6Human IL-6 / IFNb2 Antibody (Merck patent anti-IL-6, Research Use)NBR-0766
OlinvacimabKDRHuman VEGFR2 / KDR / CD309 Antibody (Olinvacimab, Research Use)NBR-0767
SiltuximabIL-6Human IL-6 / IFNb2 Antibody (Siltuximab, Research Use)NBR-0768
SirukumabIL-6Human IL-6 / IFNb2 Antibody (Sirukumab, Research Use)NBR-0769
ZiltivekimabIL-6Human IL-6 / IFNb2 Antibody (Ziltivekimab, Research Use)NBR-0770
APX007IL-6RaHuman IL-6Ra / CD126 Antibody (APX007, Research Use)NBR-0771
LevilimabIL-6RaHuman IL-6Ra / CD126 Antibody (Levilimab, Research Use)NBR-0772
SapelizumabIL-6RaHuman IL-6Ra / CD126 Antibody (Sapelizumab, Research Use)NBR-0773
OlokizumabIL-6Human IL-6 / IFNb2 Antibody (Olokizumab, Research Use)NBR-0774
OmalizumabIGHEHuman IgE Antibody (Omalizumab, Research Use)NBR-0775
OmburtamabCD276Human B7-H3 / CD276 Antibody (Omburtamab, Research Use)NBR-0776
PF-06342674IL-7RaHuman IL-7Ra / CD127 Antibody (PF-06342674, Research Use)NBR-0777
OngericimabPCSK9Human PCSK9 Antibody (Ongericimab, Research Use)NBR-0778
VatelizumabITGA2 & ITGB1Human Integrin a2b1 (ITGA2 & ITGB1) Antibody (Vatelizumab, Research Use)NBR-0779
BMS patent anti-Integrin α5β1ITGA5 & ITGB1Human Integrin a5b1 (ITGA5 & ITGB1) Antibody (BMS patent anti-Integrin α5β1, Research Use)NBR-0780
Efalizumab ITGALHuman Integrin aL / ITGAL / CD11a Antibody (Efalizumab, Research Use)NBR-0781
AbituzumabITGAVHuman Integrin aV / ITGAV / CD51 Antibody (Abituzumab, Research Use)NBR-0782
IntetumumabITGAVHuman Integrin aV / ITGAV / CD51 Antibody (Intetumumab, Research Use)NBR-0783
EtaracizumabITGAV & ITGB3Human Integrin aVb3 (ITGAV & ITGB3) Antibody (Etaracizumab, Research Use)NBR-0784
Opicinumab LINGO1Human LINGO1 Antibody (Opicinumab, Research Use)NBR-0785
Oportuzumab EPCAMHuman EpCAM / TROP1 / CD326 Antibody (Oportuzumab, Research Use)NBR-0786
EncelimabLAG3Human LAG3 / CD223 Antibody (Encelimab, Research Use)NBR-0787
FavezelimabLAG3Human LAG3 / CD223 Antibody (Favezelimab, Research Use)NBR-0788
FianlimabLAG3Human LAG3 / CD223 Antibody (Fianlimab, Research Use)NBR-0789
IeramilimabLAG3Human LAG3 / CD223 Antibody (Ieramilimab, Research Use)NBR-0790
MiptenalimabLAG3Human LAG3 / CD223 Antibody (Miptenalimab, Research Use)NBR-0791
Opucolimab CD274Human B7-H1 / PD-L1 / CD274 Antibody (Opucolimab, Research Use)NBR-0792
LadiratuzumAb SLC39A6Human LIV-1 / SLC39A6 Antibody (LadiratuzumAb, Research Use)NBR-0793
Organon patent anti-CD27 CD27Human TNFRSF7 / CD27 Antibody (Organon patent anti-CD27, Research Use)NBR-0794
OrilanolimabFCGRTHuman FcRn (FCGRT & B2M) Antibody (Orilanolimab, Research Use)NBR-0795
OrticumabOLR1Human oxLDL Antibody (Orticumab, Research Use)NBR-0796
ORY012AXLHuman AXL / UFO Antibody (ORY012, Research Use)NBR-0797
BMS-986148MSLNHuman Mesothelin Antibody (BMS-986148, Research Use)NBR-0798
OsocimabF11Human F11 / Factor XI Antibody (Osocimab, Research Use)NBR-0799
Yeda patent anti-MMP-9MMP9Human MMP9 Antibody (Yeda patent anti-MMP-9, Research Use)NBR-0800
Otelixizumab CD3EHuman CD3 Antibody (Otelixizumab, Research Use)NBR-0801
OtilimabCSF2Human CSF2 / GM-CSF Antibody (Otilimab, Research Use)NBR-0802
AR20.5 MUC1Human MUC1 Antibody (AR20.5, Research Use)NBR-0803
OtlertuzumabCD37Human TSPAN26 / CD37 Antibody (Otlertuzumab, Research Use)NBR-0804
Oxford Brookes U. patent anti-Activin Beta-BINHBBHuman INHBB / Activin B Antibody (Oxford Brookes U. patent anti-Activin Beta-B, Research Use)NBR-0805
Imaprelimab MCAMHuman MUC18 / MCAM / CD146 Antibody (Imaprelimab, Research Use)NBR-0806
AS2886401-00NGFHuman NGF / bNGF Antibody (AS2886401-00, Research Use)NBR-0807
FasinumabNGFHuman NGF / bNGF Antibody (Fasinumab, Research Use)NBR-0808
MEDI-578NGFHuman NGF / bNGF Antibody (MEDI-578, Research Use)NBR-0809
PG110NGFHuman NGF / bNGF Antibody (PG110, Research Use)NBR-0810
UliledlimabNT5EHuman NT5E / CD73 Antibody (Uliledlimab, Research Use)NBR-0811
Pfizer patent anti-Notch1NOTCH1Human NOTCH1 Antibody (Pfizer patent anti-Notch1, Research Use)NBR-0812
VixarelimabOSMRHuman OSMR Antibody (Vixarelimab, Research Use)NBR-0813
ASK8007 SPP1Human Osteopontin Antibody (ASK8007, Research Use)NBR-0814
PlonmarlimabCSF2Human CSF2 / GM-CSF Antibody (Plonmarlimab, Research Use)NBR-0815
Ponezumab APPHuman Amyloid Beta Antibody (Ponezumab, Research Use)NBR-0816
ZelminemabPAC1Human PAC1 Antibody (Zelminemab, Research Use)NBR-0817
Ponsegromab GDF15Human GDF15 / MIC-1 Antibody (Ponsegromab, Research Use)NBR-0818
Amgen patent anti-PAR-2PAR2Human PAR2 Antibody (Amgen patent anti-PAR-2, Research Use)NBR-0819
PozelimabC5Human Complement C5 Antibody (Pozelimab, Research Use)NBR-0820
U.Penn. patent anti-PCLAPLCAHuman PCLA Antibody (U.Penn. patent anti-PCLA, Research Use)NBR-0821
ProlgolimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Prolgolimab, Research Use)NBR-0822
Quark patent anti-ENDO 180 MRC2Human MRC2 / CD280 Antibody (Quark patent anti-ENDO 180, Research Use)NBR-0823
Quavonlimab CTLA4Human CTLA-4 / CD152  Antibody (Quavonlimab, Research Use)NBR-0824
RacotumomabST3GAL5Human GM3 Antibody (Racotumomab, Research Use)NBR-0825
Merck patent anti-PCSK9PCSK9Human PCSK9 Antibody (Merck patent anti-PCSK9, Research Use)NBR-0826
RalpancizumabPCSK9Human PCSK9 Antibody (Ralpancizumab, Research Use)NBR-0827
RecaticimabPCSK9Human PCSK9 Antibody (Recaticimab, Research Use)NBR-0828
RG7652PCSK9Human PCSK9 Antibody (RG7652, Research Use)NBR-0829
Schering patent anti-PCSK9PCSK9Human PCSK9 Antibody (Schering patent anti-PCSK9, Research Use)NBR-0830
Regeneron patent anti-ASIC1 ASIC1Human ASIC1 Antibody (Regeneron patent anti-ASIC1, Research Use)NBR-0831
BalstilimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Balstilimab, Research Use)NBR-0832
BudigalimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Budigalimab, Research Use)NBR-0833
CetrelimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Cetrelimab, Research Use)NBR-0834
Regeneron patent anti-CD20CD20Human CD20 Antibody (Regeneron patent anti-CD20, Research Use)NBR-0835
EzabenlimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Ezabenlimab, Research Use)NBR-0836
Regeneron patent anti-EGFRERBB1Human ERBB1 / EGFR / HER1 Antibody (Regeneron patent anti-EGFR, Research Use)NBR-0837
Regeneron patent anti-PAR-2PAR2Human PAR2 Antibody (Regeneron patent anti-PAR-2, Research Use)NBR-0838
PenpulimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Penpulimab, Research Use)NBR-0839
PidilizumabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Pidilizumab, Research Use)NBR-0840
PimivalimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Pimivalimab, Research Use)NBR-0841
RetifanlimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Retifanlimab, Research Use)NBR-0842
SasanlimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Sasanlimab, Research Use)NBR-0843
SerplulimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Serplulimab, Research Use)NBR-0844
SintilimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Sintilimab, Research Use)NBR-0845
TislelizumabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Tislelizumab, Research Use)NBR-0846
UCB patent anti-PD-1PDCD1Human PDCD1 / PD-1 / CD279 Antibody (UCB patent anti-PD-1, Research Use)NBR-0847
ZimberelimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Zimberelimab, Research Use)NBR-0848
RevdofilimabTNFRSF4Human TNFRSF4 / OX40 / CD134 Antibody (Revdofilimab, Research Use)NBR-0849
RO5458640TNFSF12Human TNFSF12 / TWEAK Antibody (RO5458640, Research Use)NBR-0850
IMC-2C5 PDGFRBHuman PDGFRB / CD140b Antibody (IMC-2C5, Research Use)NBR-0851
RobatumumabIGF1RHuman IGF1R / CD221 Antibody (Robatumumab, Research Use)NBR-0852
BavituximabN/AHuman Phosphatidylserine Antibody (Bavituximab, Research Use)NBR-0853
Roche patent anti-ANG-2ANGPT2Human ANGPT2 Antibody (Roche patent anti-ANG-2, Research Use)NBR-0854
Roche patent anti-CCN1 CCN1Human CYR61 / CCN1 Antibody (Roche patent anti-CCN1, Research Use)NBR-0855
BAY 1158061PRLRHuman PRLR / Prolactin Receptor Antibody (BAY 1158061, Research Use)NBR-0856
Rockefeller U. patent anti-Amyloid Beta APPHuman Amyloid Beta Antibody (Rockefeller U. patent anti-Amyloid Beta, Research Use)NBR-0857
RoledumabCD240dHuman RHD / CD240d Antibody (Roledumab, Research Use)NBR-0858
Medella patent anti-RAMP-3 RAMP3Human RAMP3 Antibody (Medella patent anti-RAMP-3, Research Use)NBR-0859
LFB Anti-RhDCD240dHuman RHD / CD240d Antibody (LFB Anti-RhD, Research Use)NBR-0860
AtinumabRTN4Human RTN4 / NOGO Antibody (Atinumab, Research Use)NBR-0861
NG-101RTN4Human RTN4 / NOGO Antibody (NG-101, Research Use)NBR-0862
LK-1 S100A4Human S100A4 Antibody (LK-1, Research Use)NBR-0863
SBI Biotech patent anti-BST2 BST2Human BST2 / CD317 Antibody (SBI Biotech patent anti-BST2, Research Use)NBR-0864
AB-25E9 SIGLEC15Human Siglec-15 / CD33L3 Antibody (AB-25E9, Research Use)NBR-0865
Medimmune patent anti-Siglec-15 SIGLEC15Human Siglec-15 / CD33L3 Antibody (Medimmune patent anti-Siglec-15, Research Use)NBR-0866
Epratuzumab CD22Human Siglec-2 / CD22 Antibody (Epratuzumab, Research Use)NBR-0867
NCI m971 CD22Human Siglec-2 / CD22 Antibody (NCI m971, Research Use)NBR-0868
NCI m972 CD22Human Siglec-2 / CD22 Antibody (NCI m972, Research Use)NBR-0869
Pinatuzumab CD22Human Siglec-2 / CD22 Antibody (Pinatuzumab, Research Use)NBR-0870
IMGN779 CD22Human Siglec-3 / CD33 Antibody (IMGN779, Research Use)NBR-0871
AzintuxizumAb SLAMF7Human SLAMF7 / CS1 Antibody (AzintuxizumAb, Research Use)NBR-0872
PDL241 SLAMF7Human SLAMF7 / CS1 Antibody (PDL241, Research Use)NBR-0873
VB1-050SLC2A8Human SLC2A8 Antibody (VB1-050, Research Use)NBR-0874
LifastuzumAbSLC34A2Human SLC34A2 Antibody (LifastuzumAb, Research Use)NBR-0875
UpifitamabSLC34A2Human SLC34A2 Antibody (Upifitamab, Research Use)NBR-0876
Solanezumab APPHuman Amyloid Beta Antibody (Solanezumab, Research Use)NBR-0877
SonepcizumabSGPP1Human Sphingosine-1-phosphate Antibody (Sonepcizumab, Research Use)NBR-0878
TadocizumabITGA2 & ITGB3Human Integrin a2b3 (ITGA2 & ITGB3) Antibody (Tadocizumab, Research Use)NBR-0879
BepranemabMAPTHuman Tau Antibody (Bepranemab, Research Use)NBR-0880
TafolecimabPCSK9Human PCSK9 Antibody (Tafolecimab, Research Use)NBR-0881
LY3022859 TGFBR2Human TBFbR2 Antibody (LY3022859, Research Use)NBR-0882
NKTT320PTCRAHuman TCR Antibody (NKTT320, Research Use)NBR-0883
TelazorlimabTNFRSF4Human TNFRSF4 / OX40 / CD134 Antibody (Telazorlimab, Research Use)NBR-0884
Tenatumomab TNCHuman Tenascin C Antibody (Tenatumomab, Research Use)NBR-0885
Marstacimab TFPIHuman TFPI Antibody (Marstacimab, Research Use)NBR-0886
NIS793TGFB1Human TGFb1 Antibody (NIS793, Research Use)NBR-0887
ZampilimabTGM2Human TGM2 / Transglutaminase 2 Antibody (Zampilimab, Research Use)NBR-0888
Etigilimab TIGITHuman TIGIT Antibody (Etigilimab, Research Use)NBR-0889
TesidolumabC5Human Complement C5 Antibody (Tesidolumab, Research Use)NBR-0890
Theraclone patent anti-GM-CSFCSF2Human CSF2 / GM-CSF Antibody (Theraclone patent anti-GM-CSF, Research Use)NBR-0891
TilavonemabMAPTHuman Tau Antibody (Tilavonemab, Research Use)NBR-0892
Chugai patent anti-TFTFHuman Tissue factor / CD142 Antibody (Chugai patent anti-TF, Research Use)NBR-0893
Tilogotamab TNFRSF10BHuman TNFRSF10B / TRAILR2 / CD262 Antibody (Tilogotamab, Research Use)NBR-0894
TNX-832TFHuman Tissue factor / CD142 Antibody (TNX-832, Research Use)NBR-0895
Benufutamab TNFRSF10BHuman TNFRSF10B / TRAILR2 / CD262 Antibody (Benufutamab, Research Use)NBR-0896
TOL101PTCRAHuman TCR Antibody (TOL101, Research Use)NBR-0897
Lexatumumab TNFRSF10BHuman TNFRSF10B / TRAILR2 / CD262 Antibody (Lexatumumab, Research Use)NBR-0898
TomuzotuximabERBB1Human ERBB1 / EGFR / HER1 Antibody (Tomuzotuximab, Research Use)NBR-0899
Toray patent anti-Caprin-1CAPRIN1Human CAPRIN1 Antibody (Toray patent anti-Caprin-1, Research Use)NBR-0900
ToripalimabPDCD1Human PDCD1 / PD-1 / CD279 Antibody (Toripalimab, Research Use)NBR-0901
BMS-986178TNFRSF4Human TNFRSF4 / OX40 / CD134 Antibody (BMS-986178, Research Use)NBR-0902
TorudokimabIL-33Human IL-33 Antibody (Torudokimab, Research Use)NBR-0903
TozorakimabIL-33Human IL-33 Antibody (Tozorakimab, Research Use)NBR-0904
U.Illinois scFv59 APPHuman Amyloid Beta Antibody (U.Illinois scFv59, Research Use)NBR-0905
IscalimabCD40Human TNFRSF5 / CD40 Antibody (Iscalimab, Research Use)NBR-0906
LucatumumabCD40Human TNFRSF5 / CD40 Antibody (Lucatumumab, Research Use)NBR-0907
MitazalimabCD40Human TNFRSF5 / CD40 Antibody (Mitazalimab, Research Use)NBR-0908
RavagalimabCD40Human TNFRSF5 / CD40 Antibody (Ravagalimab, Research Use)NBR-0909
U.Rochester patent anti-DC-STAMPDCSTAMPHuman DCSTAMP Antibody (U.Rochester patent anti-DC-STAMP, Research Use)NBR-0910
PateclizumabTNFSF1Human TNFSF1 / TNFb Antibody (Pateclizumab, Research Use)NBR-0911
U.Washington patent anti-GAD65GAD2Human GAD65 Antibody (U.Washington patent anti-GAD65, Research Use)NBR-0912
U.Washington patent anti-MICBMICBHuman MICB Antibody (U.Washington patent anti-MICB, Research Use)NBR-0913
SibeprenlimabTNFSF13Human TNFSF13 / APRIL / CD256 Antibody (Sibeprenlimab, Research Use)NBR-0914
Tabalumab TNFSF13BHuman TNFSF13B / BAFF / CD257 Antibody (Tabalumab, Research Use)NBR-0915
SAR252067 TNFSF14Human TNFSF14 / LIGHT / CD258 Antibody (SAR252067, Research Use)NBR-0916
CDP571TNFSF2Human TNFSF2 / TNFa Antibody (CDP571, Research Use)NBR-0917
U.Zurich patent anti-Amyloid Beta APPHuman Amyloid Beta Antibody (U.Zurich patent anti-Amyloid Beta, Research Use)NBR-0918
CMAB008TNFSF2Human TNFSF2 / TNFa Antibody (CMAB008, Research Use)NBR-0919
ESBA 105TNFSF2Human TNFSF2 / TNFa Antibody (ESBA 105, Research Use)NBR-0920
HMAK195TNFSF2Human TNFSF2 / TNFa Antibody (HMAK195, Research Use)NBR-0921
Vedolizumab ITGA4 & ITGB7Human Integrin a4b7 (ITGA4 & ITGB7) Antibody (Vedolizumab, Research Use)NBR-0922
RuplizumabCD40LGHuman TNFSF5 / CD40L / CD154 Antibody (Ruplizumab, Research Use)NBR-0923
VibostolimabTIGITHuman TIGIT Antibody (Vibostolimab, Research Use)NBR-0924
VilobelimabC5Human Complement C5 Antibody (Vilobelimab, Research Use)NBR-0925
Wyeth patent anti-5T4TPBGHuman TPBG Antibody (Wyeth patent anti-5T4, Research Use)NBR-0926
Rinat patent anti-TrkB NTRK2Human TrkB / NTRK2 Antibody (Rinat patent anti-TrkB, Research Use)NBR-0927
Schering patent anti-TSLPTSLPHuman TSLP Antibody (Schering patent anti-TSLP, Research Use)NBR-0928
AGS67ECD37Human TSPAN26 / CD37 Antibody (AGS67E, Research Use)NBR-0929
VolociximabITGA5 & ITGB1Human Integrin a5b1 (ITGA5 & ITGB1) Antibody (Volociximab, Research Use)NBR-0930
VonlerizumabTNFRSF4Human TNFRSF4 / OX40 / CD134 Antibody (Vonlerizumab, Research Use)NBR-0931
Hanwha patent anti-VCAM-1 VCAM1Human VCAM1 / CD106 Antibody (Hanwha patent anti-VCAM-1, Research Use)NBR-0932
ZagotenemabMAPTHuman Tau Antibody (Zagotenemab, Research Use)NBR-0933
RanibizumabVEGFAHuman VEGFA Antibody (Ranibizumab, Research Use)NBR-0934
VarisacumabVEGFAHuman VEGFA Antibody (Varisacumab, Research Use)NBR-0935
VGX100VEGFCHuman VEGFC Antibody (VGX100, Research Use)NBR-0936
AlacizumAbKDRHuman VEGFR2 / KDR / CD309 Antibody (AlacizumAb, Research Use)NBR-0937
AT001KDRHuman VEGFR2 / KDR / CD309 Antibody (AT001, Research Use)NBR-0938
VulinacimabKDRHuman VEGFR2 / KDR / CD309 Antibody (Vulinacimab, Research Use)NBR-0939
LY3022856 FLT4Human VEGFR3 / FLT4 Antibody (LY3022856, Research Use)NBR-0940
Bapineuzumab APPHuman Amyloid Beta Antibody (Bapineuzumab, Research Use)NBR-0941
Lecanemab APPHuman Amyloid Beta Antibody (Lecanemab, Research Use)NBR-0942
Antitope patent anti-CTLA4CD152Human CTLA-4 / CD152 Antibody (Antitope patent anti-CTLA4, Research Use)NBR-0943
BioMab patent anti-Her2ERBB2Human ERBB2 / HER2 / CD340 Antibody (BioMab patent anti-Her2, Research Use)NBR-0944
BioMab patent anti-VEGFVEGFAHuman VEGF Antibody (BioMab patent anti-VEGF, Research Use)NBR-0945
Centocor patent anti-GLP-1R GLP1RHuman GLP1R Antibody (Centocor patent anti-GLP-1R, Research Use)NBR-0946
AxatilimabCSF1RHuman CSF1R / M-CSFR / CD115 Antibody (Axatilimab, Research Use)NBR-0947
Immunomedics patent anti-CEACAM5 (Class III)CD66aHuman CEACAM5 / CEA / CD66e Antibody (Immunomedics patent anti-CEACAM5 (Class III), Research Use)NBR-0948
Naxitamab
Human GD2 Antibody (Naxitamab, Research Use)NBR-0949
Medarex patent anti-IFNAR-1IFNAR1Human IFNARa1 Antibody (Medarex patent anti-IFNAR-1, Research Use)NBR-0950
ObexelimabCD19Human CD19 Antibody (Obexelimab, Research Use)NBR-0951
Genzyme patent anti-TGF-βTGFB1Human TGFb1 Antibody (Genzyme patent anti-TGF-β, Research Use)NBR-0952
TezepelumabTSLPHuman TSLP Antibody (Tezepelumab, Research Use)NBR-0953
IgG1+Kappa Isotype ControlABMHuman Abm Antibody (IgG1+Kappa Isotype Control, Research Use)NBR-0954
IgG4+Kappa Isotype ControlABMHuman Abm Antibody (IgG4+Kappa Isotype Control, Research Use)NBR-0955
PritoxaximabShiga toxin (E.coli)Human Shiga toxin (E.coli) Antibody (Pritoxaximab, Research Use)NBR-0956
SetoxaximabShiga toxin (E.coli)Human Shiga toxin (E.coli) Antibody (Setoxaximab, Research Use)NBR-0957
OST 577HBsAgHuman HBsAg Antibody (OST 577, Research Use)NBR-0958
ForavirumabRabies virus GPHuman Rabies virus GP Antibody (Foravirumab, Research Use)NBR-0959
RafivirumabRabies virus GPHuman Rabies virus GP Antibody (Rafivirumab, Research Use)NBR-0960
MotavizumabRSV-FHuman RSV-F Antibody (Motavizumab, Research Use)NBR-0961
PalivizumabRSV-FHuman RSV-F Antibody (Palivizumab, Research Use)NBR-0962
MetelimumabTGFB1Human TGFB1 Antibody (Metelimumab, Research Use)NBR-0963
BimekizumabCTLA-8Human IL17A, IL-17F, IL17AF Antibody (Bimekizumab, Research Use)NBR-0964
PanitumumabVEGFHuman EGFR Antibody (Panitumumab, Research Use)NBR-0965
Datopotamab TACSTD2Human TROP2 Antibody (Datopotamab, Research Use)NBR-0966
Praluzatamab-MMAEALCAM / CD166Anti-ALCAM / CD166 Reference Antibody (Praluzatamab-MMAE)NBR-1000
Murlentamab-MMAEAMHR2Anti-AMHR2 Reference Antibody (Murlentamab-MMAE)NBR-1001
Enapotamab vedotinAXL / UFOAnti-AXL / UFO Reference Antibody (Enapotamab vedotin)NBR-1002
Tilvestamab-MMAEAXL / UFOAnti-AXL / UFO Reference Antibody (Tilvestamab-MMAE)NBR-1003
oregovomab-MMAECA125 / MUC16Anti-MUC16 Reference Antibody (oregovomab-MMAE)NBR-1004
Sofituzumab vedotinCA125 / MUC16Anti-MUC16 Reference Antibody (Sofituzumab vedotin)NBR-1005
girentuximab-MMAECA9 / Carbonic anhydrase 9Anti-CA9 / CAIX Reference Antibody (girentuximab-MMAE)NBR-1006
denintuzumab-MMAFCD19Anti-CD19 Reference Antibody (denintuzumab-MMAF)NBR-1007
Polatuzumab vedotin-piiqCD79bAnti-CD79b Reference Antibody (Polatuzumab vedotin-piiq)NBR-1008
iladatuzumab vedotinCD79bAnti-CD79b Reference Antibody (iladatuzumab vedotin)NBR-1009
labetuzumab govitecanCEACAM5 / CEA / CD66eAnti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab govitecan)NBR-1010
Tusamitamab-MMAECEACAM5 / CEA / CD66eAnti-CEACAM5 / CEA / CD66e Reference Antibody (Tusamitamab-MMAE)NBR-1011
zolbetuximab MMAECLDN18.2Anti-CLDN18.2 Reference Antibody (zolbetuximab MMAE)NBR-1012
ulocuplumab-MMAECXCR4 / CD184Anti-CXCR4/CD184 Reference Antibody (ulocuplumab-MMAE)NBR-1013
rovalpituzumab-MMAEDLL3Anti-DLL3 Reference Antibody (rovalpituzumab-MMAE)NBR-1014
carotuximab-MMAEEndoglin / CD105Anti-Endoglin / CD105 Reference Antibody (carotuximab-MMAE)NBR-1015
depatuxizumab-MMAFERBB1 / EGFR / HER1Anti-ERBB1 / EGFR / HER1 Reference Antibody (depatuxizumab-MMAF)NBR-1016
Cetuximab-MMAEERBB1 / EGFR / HER1Anti-ERBB1 / EGFR / HER1 Reference Antibody (Cetuximab-MMAE)NBR-1017
Disitamab vedotinERBB2 / HER2 / CD340Anti-ERBB2 / HER2 / CD340 Reference Antibody (Disitamab vedotin)NBR-1018
Trastuzumab-MMAEERBB2 / HER2 / CD340Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab-MMAE)NBR-1019
patritumab-MMAEERBB3 / HER3Anti-ERBB3/ HER3 Reference Antibody (patritumab-MMAE)NBR-1020
Patritumab deruxtecanERBB3 / HER3Anti-ERBB3/ HER3 Reference Antibody (Patritumab deruxtecan)NBR-1021
rosopatamab-MMAEFOLH1 / PSMAAnti-FOLH1 / PSMA Reference Antibody (rosopatamab-MMAE)NBR-1022
farletuzumab-MMAEFOLR1 / FRAAnti-FOLR1 / FRA Reference Antibody (farletuzumab-MMAE)NBR-1023
mirvetuximab-MMAEFOLR1 / FRAAnti-FOLR1 / FRA Reference Antibody (mirvetuximab-MMAE)NBR-1024
ecromeximab-MMAEGD3Anti-GD3 Reference Antibody (ecromeximab-MMAE)NBR-1025
Codrituzumab-MMAEGPC3 / Glypican-3Anti-GPC3 / Glypican-3 Reference Antibody (Codrituzumab-MMAE)NBR-1026
Glembatumumab vedotinGPNMBAnti-GPNMB Reference Antibody (Glembatumumab vedotin)NBR-1027
Indusatumab vedotinGUCY2CAnti-GUCY2C Reference Antibody (Indusatumab vedotin)NBR-1028
Telisotuzumab vedotinHGFR / c-MetAnti-HGFR / c-Met Reference Antibody (Telisotuzumab vedotin)NBR-1029
talacotuzumab-MMAEIL-3Ra / CD123Anti-IL-3Ra / CD123 Reference Antibody (talacotuzumab-MMAE)NBR-1030
ADCT-901-MMAEKAAG1Anti-KAAG1 Reference Antibody (ADCT-901-MMAE)NBR-1031
Ladiratuzumab vedotinLIV-1 / SLC39A6Anti-LIV-1 / SLC39A6 Reference Antibody (Ladiratuzumab vedotin)NBR-1032
anetumab-MMAEMesothelinAnti-Mesothelin Reference Antibody (anetumab-MMAE)NBR-1033
ensituximab-MMAEMU5ACAnti-MU5AC Reference Antibody (ensituximab-MMAE)NBR-1034
clivatuzumab-MMAEMUC1Anti-MUC1 Reference Antibody (clivatuzumab-MMAE)NBR-1035
Lifastuzumab vedotinNaPi2b / SLC34A2Anti-NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab vedotin)NBR-1036
lorvotuzumab-MMAENCAM1 / CD56Anti-NCAM1 / CD56 Reference Antibody (lorvotuzumab-MMAE)NBR-1037
enfortumab vedotin-ejfvNectin-4Anti-Nectin-4 Reference Antibody (enfortumab vedotin-ejfv)NBR-1038
Zilovertamab vedotinROR1Anti-ROR1 Reference Antibody (Zilovertamab vedotin)NBR-1039
ozuriftamab vedotinROR2Anti-ROR2 Reference Antibody (ozuriftamab vedotin)NBR-1040
Pinatuzumab vedotinSiglec-2 / CD22Anti-Siglec-2 / CD22 Reference Antibody (Pinatuzumab vedotin)NBR-1041
inotuzumab-MMAESiglec-2 / CD22Anti-Siglec-2 / CD22 Reference Antibody (inotuzumab-MMAE)NBR-1042
Sirtratumab vedotinSLITRK6Anti-SLITRK6 Reference Antibody (Sirtratumab vedotin)NBR-1043
tisotumab vedotinTF / Factor III / Tissue Factor / CD142Anti-TF / Factor III / Tissue Factor / CD142 Reference Antibody (tisotumab vedotin)NBR-1044
brentuximab vedotinTNFRSF8 / CD30Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin)NBR-1045
Vorsetuzumab mafodotinTNFSF7 / CD27L / CD70Anti-TNFSF7 / CD27L / CD70 Reference Antibody (Vorsetuzumab mafodotin)NBR-1046
datopotamab deruxtecanTROP2Anti-TROP2 Reference Antibody (datopotamab deruxtecan)NBR-1047
Sacituzumab-MMAETROP2Anti-TROP2 Reference Antibody (Sacituzumab-MMAE)NBR-1048


关键词:Alpha-fetoprotein抗体,CD19抗体,CD28抗体,CD40抗体,CD40L抗体,CD70抗体,B7-2抗体,CDK4抗体,CEACAM-5抗体,CTLA-4抗体,IL-8抗体,VEGFR2抗体,KRAS抗体,LAG-3抗体,TNFRSF5抗体,TNFSF5抗体,CD27抗体,CD86抗体,CD66e抗体,CXCL8抗体,KDR抗体,Anti-Alpha-fetoprotein,Anti-CD19,Anti-CD28,Anti-CD40,Anti-CD40L,Anti-CD70,Anti-B7-2,Anti-CDK4,Anti-CEACAM-5,Anti-CTLA-4,Anti-IL-8,Anti-VEGFR2,Anti-KRAS,Anti-LAG-3,Anti-TNFRSF5,Anti-TNFSF5,Anti-CD27,Anti-CD86,Anti-CD66e,Anti-CXCL8,Anti-KDR,抗Alpha-fetoprotein单抗,抗CD19单抗,抗CD28单抗,抗CD40单抗,抗CD40L单抗,抗CD70单抗,抗B7-2单抗,抗CDK4单抗,抗CEACAM-5单抗,抗CTLA-4单抗,抗IL-8单抗,抗VEGFR2单抗,抗KRAS单抗,抗LAG-3单抗,抗TNFRSF5单抗,抗TNFSF5单抗,抗CD27单抗,抗CD86单抗,抗CD66e单抗,抗CXCL8单抗,抗KDR单抗


Release time:2025-02-21